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ABSTRACT 
 
TITLE OF THE STUDY: Factors affecting delay in early diagnosis and initiation of 
treatment for tuberculosis in Vellore district-Tamil Nadu. 
DEPARTMENT: Community Health And Development 
NAME OF THE CANDIDATE: Dr. Siddabathula Harika 
DEGREE AND SUBJECT: MD; Community Medicine 
NAME OF THE GUIDE: Dr. Jasmin Helan 
Objectives:  
 
Tuberculosis is the leading killer, affecting adults in the developing countries. 
Estimates suggest that an untreated, smear positive patient can infect, on an average10 
contacts annually and more than 20 during the course of the disease. A delay in TB 
diagnosis may lead to more advanced disease state at presentation. Late-stage 
presentation may contribute to a poor response to treatment, resulting in more severe 
morbidity while increasing the risk of transmission. It is important to identify the 
causes of such delays to efficiently take measures to achieve target of case detection 
and elimination. 
Methods: 
The present study is a cross sectional study. The main objectives of this study were to 
find the average delay in diagnosis/treatment in TB and to identify the determinants of 
delay in treatment seeking including perceived stigma. The study is done among the 
newly diagnosed sputum positive tuberculosis patients who were registered in the 
Tuberculosis Unit run by the Community Health Department of Christian Medical 
College, Vellore. After obtaining informed consent, study participants were 
interviewed by the investigator using a structured questionnaire. To study the level of 
perceived stigma related to Tuberculosis, 100 people from rural area were 
interviewed. Data was entered using Epidata and analysis was done using SPSS. 
 
Results with conclusions: 
We included 95 patients with TB and 100 from general population to know stigma in 
community. The mean total delay from the onset of disease to initiation of treatment 
was 104.8 days. The patient delay, health system delay, centre delay and treatment 
delay were 38.5, 99.3, 60.8 and 2 days respectively. The median total delay, patient 
delay, health system delay, centre delay and treatment delay were 91, 20, 90, 16, and 2 
days respectively.  
Participants with TB were found to have more perception of stigma 
(p=<0.001.OR=7.19). Among the general population, participants with good 
knowledge had more perception of stigma (OR=2.40, P=0.003). Other factors that 
were independently associated with delay were low SES (P=0.03, OR=2.77) and more 
number of health centres visited (p=<0.001, OR= 5.682).  
In order to minimize the level of perceived stigma related to TB and to improve early 
health seeking, awareness should be created in the general population regarding the 
transmission of TB. Awareness need to be created on complications of not treating 
early and the high cure rate with early treatment and the type of health facility where 
screening can be done. 
From this study it is imperative that the local medical practitioners should be 
motivated to screen for Tuberculosis at the first onset of symptoms. Frequent 
continuing medical education sessions may improve case finding and minimize the 
delay.  As most people choose to go to private practitioners for the chest symptom, 
more diagnostic facility to test sputum should be made available.  
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Introduction 
Tuberculosis is a widespread disease. The disease is fatal in many cases as it is caused 
by different strains of Mycobacterium tuberculosis. Tuberculosis bacilli attacks lungs, 
however other parts of the body are not exempted. The disease is contagious and 
spreads through the air. Tuberculosis spreads through contact with the person who is 
infected, as they cough or sneeze. Most of them are asymptomatic, also called as 
latent TB infection(1). In 90% of cases the tuberculosis bacilli attacks lungs. When 
lungs are affected the symptoms includes prolonged cough with sputum production, 
25% of the people may remain asymptomatic. A vaccine against TB is available 
nearly for a century. Effective treatment for TB is available nearly for 60 years. Yet 
the disease is close to its highest levels ever seen. It remains a potentially fatal disease 
still. 
Every year 6 million people die of HIV/AIDS, TB and malaria. Among all these 
deaths tuberculosis attributes to 2 million deaths. TB is a pandemic; half of all 
reported cases are in 6 Asian countries – Bangladesh, China, India, Indonesia, 
Philippines and Pakistan. But a highest rate of per capita cases are from African 
countries i.e. it includes one-fourth of all the TB case. Tuberculosis is the leading 
killer, affecting adults in the developing countries. It was the seventh most leading 
cause of morbidity in 1990. The trend is expected to continue till 2020.In 2001; 1.86 
billion persons were infected with tuberculosis according to WHO estimates. Statistics 
shows that each year 8.74 million people may get infected with tuberculosis and of 
these nearly 2 million die of the disease(2). 
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As per the statistics it comes to light that someone somewhere gets affected and dies 
of TB every 10 seconds. Hence in 1993, TB is declared as global emergency by the 
WHO. According to the estimates it showed that 37 million people were saved 
between 2000 to 2013 with effective diagnosis and treatment. However in 2013, it was 
estimated that those affected with TB attributed to 9 million and among those who 
died of the disease were 1.5million; of which 360,000 were HIV-positive.  
India has the highest burden of TB. Global incidence of TB is 9 million cases, out of 
which 2.1 million cases of TB incidence is reported in India according to WHO 
estimates in 2013. 
The estimated figure for prevalence is 2.6 million as per 2013 WHO statistics(3).TB 
was declared as a notifiable disease in 2012, which means with immediate effect all 
private doctors, caregivers and clinics who involved in treating a TB patient should 
report every case of TB to the government(4). India and China alone contributes to 35 
% of cases reported in 2013. According to Global tuberculosis report-2014 published 
by WHO, 6.1 million TB cases were reported in 2013.Of the reported, 5.7 million 
people were newly diagnosed and 0.4 million were already on treatment(3). The 
reasons proposed for rampant increase in disease within the developing world are 
population explosion, inadequate coverage by control programs, poor cure rates, 
interaction of HIV with TB(5).as 90% of the infection is symptomatic ,some develop 
infection before their immune system could get  activated. The infection usually 
progresses within weeks. 25% of the populations stay as carriers or asymptomatic to 
the infection, of which those who develop latent infection with no treatment comes to 
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5-10%. It affects those whose immune system is weak. People who are at high risk for 
developing TB fall into two categories 
a. Persons recently infected with TB. 
b. Persons with conditions that weaken the immune system which facilitate the 
growth of the TB bacteria(6). 
The efforts to combat TB were severely affected for stigma being one of the 
reason(7). There is vast literature available to understand available to understand the 
factors related or affecting delay in the health seeking behaviour which reflects on 
early diagnosis and initiation of the treatment in TB patients(8). Apart from socio 
economic status, knowledge about TB, smoking and other personal characteristics; 
psychosocial factors also play an important role in the diagnosis of TB(9). The psycho 
social factors include stigma in the case TB, which may cause rejection, shame, 
blame, exclusion from those of healthy individuals(10). There is a great evidence from 
various  studies which suggest that stigma associated with TB could be a reason in 
delay in seeking health care in TB patients(11).one of the factor highlighted from 
other studies was many of the patients had the fear that their disease would be labelled 
as related to AIDS(12). The present study may unfold the scenario in the rural part of 
Tamil Nadu, Vellore which aids to understand various reasons of delay including 
stigma in early diagnosis of TB and further initiation of treatment in newly diagnosed 
sputum positive patients. 
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Justification 
Tuberculosis (TB) is a public health threat globally. The disease causing 
organism is ubiquitous and is widespread. According to WHO report, an 
estimated9.0 million people had TB disease in 2013 and 1.5 million people deaths 
due to TB were reported(13).  
The World Health Organization’s (WHO’s) under Direct Observed Therapy-Short 
course (DOTS) strategy; to increase TB success emphasizes on passive case 
finding. This leaves onus on the patient to approach health facility, making the 
patient vulnerable to delay in seeking care for their symptoms. This delay may 
further increase transmission of TB in the community. TB transmission most often 
occurs between the onset of cough and also after a few weeks after the initiation 
of treatment. According to estimates an untreated, smear positive patient can 
infect, on an average of 10 contacts annually and more than 20 during the course 
of the disease(14). 
Notoriously the delay may cause the disease to progress to an advanced stage at 
presentation. With increased bacillary and presentation after a longer period of 
delay may contribute to poor response to treatment. This further result in increase 
in morbidity and also will increase the risk of transmission. The proportion of 
contacts found to be infected at the time of diagnosis of a smear-positive index 
case is around 30%–40% (15).  
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The increase in severe morbidity of an undiagnosed or late diagnosed TB signifies 
the importance to identify various causes of delay. This aids in taking active 
measure to achieve target of case detection and elimination. Recent studies done 
in high-burden TB countries reveals that improving case finding may save 10 
times as many lives saved by as DOTS alone(16). 
Though there are numerous factors which contribute to delay either due to system 
or by the patient, in order to improve case finding under RNTCP; it is important to 
identify and address these factors. Patient’s demographic profile, social economic 
status, and accessibility of the healthcare facilities, availability of competent staff 
and diagnostic equipment determine passive case finding(17). 
These similar factors are identified to be the reasons for delay in many countries. 
Such delay may occur at the level of the patient (patient delay) or at the level of 
the health system (system delay) (5-8).  
Poverty is one major reason for not seeking proper treatment among both men and 
women (10). However, decision to go for treatment outside home had been a 
limiting factor for women compared to men (6). Out-of-pocket expenditure on 
multiple consultations with local practitioners before diagnosis, lack of money for 
transport also contributes to delay in proper diagnosis (11). 
Stigma, attached to TB, as shown in many studies seems to be a main reason for 
patient delay. Study in Pakistan showed that majority (85%) of patients felt 
ashamed to disclose the disease (6). TB and HIV co-infection has also affected the 
stigma (12). A multi-country study showed that stigma attached to TB is much 
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more in India than other countries (13). Though there are many studies available 
from different countries, there is no study from this area assessing the delay, out-
of-pocket expenditure prior to diagnosis and the level of perceived stigma. 
Various studies have demonstrated increased level of perceived stigma among 
people with tuberculosis.  There is lack of information on community’s perception 
towards stigma related to TB. This study attempts to address these issues (13).   
 
. 
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3. Aims and objectives: 
3.1 Aim:  
The aim of this study is to find out the factors affecting delay in early diagnosis and 
initiation of treatment for tuberculosis among newly diagnosed sputum positive 
tuberculosis patients registering in CHAD Tuberculosis Unit (TU) during the period 
from November 2014 to May 2015. 
3.2 Objectives: 
1) To study the delay in diagnosis and initiation of treatment in 
tuberculosis  
2) To study the determinants of delay in diagnosis and initiation of 
treatment in tuberculosis 
3) To compare the knowledge and perceived stigma towards tuberculosis 
among people with tuberculosis and among the people without 
tuberculosis. 
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4. Literature review 
Tuberculosis is a major global health problem. It is caused by Mycobacterium 
tuberculosis. It is second leading cause of death worldwide; among the infectious 
diseases after human immune deficiency virus (HIV). Human beings are its natural 
reservoir of host. Due to its ability to establish latent infection, it spread to one third of 
the population worldwide. According to the WHO report of 2013 is estimated that 
new TB cases accounts to 9 million and TB deaths up to1.5 million(13). 
4.1Pathogenesis of tuberculosis 
4.1.1 Microbiology:  
M.tuberculosis belongs to the genus Mycobacterium. Tuberculosis (TB) is defined as 
a disease caused by members of the M.tuberculosis complex. It includes the tubercle 
bacillus (M. tuberculosis), M. bovis, M. africanum, M. microti, M. canetti, M. caprae, 
and M. pinnipedii(18). 
TB affects lungs in 85% of cases. Other sites include lymph nodes, genitourinary tract, 
bones and joints, intestine, skin. 
4.1.2Characteristics of Mycobacterium tuberculosis: 
As shown in the figure 4.1, it is a rod shaped bacteria of 0.2 to 0.5 microns (6). 
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It`s cell wall is composed of mycolic acid which stains it acid fast; an acid fast bacilli. 
It resists acid or alcohol for decolourisation. It is an aerobic bacteria and motile, which 
multiplies slowly. It has the capacity to remain dormant for decades (6). 
Figure 4.1- TB bacilli 
 
 
4.1.3 NATURAL HISTORY OF THE DISEASE 
The aerosol droplets containing Mycobacterium tuberculosis when inhaled causes 
deposition in the lungs and leads to one of the possible outcomes. The outcomes may 
include either immediate clearance of the organism or primary disease (immediate 
onset of active disease), latent infection, reactivation disease (onset of active disease 
many years following a period of latent infection) (19). 
 
 
Source: internet www.cdc.org 
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4.1.4 Primary disease: 
Approximately 5 t0 10% of the individuals of all the exposed will develop active 
disease. Among these half of them will develop TB in first two to three years 
following infection. 
The droplets size (5 to 10 microns) is small enough to reach alveoli; the tubercle 
bacilli are carried in these small droplets to reach the lung. When it comes to 
multiplication of tubercle bacilli the innate immune system stands as a failure to 
eliminate the infection. The bacilli proliferate in the alveolar macrophages and further 
migrate from lungs to other tissue. 
Figure 4.2-droplet transmission of TB 
 
Source: internet www.cdc.org 
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In the lungs the macrophages produce cytokines and chemokines. These cytokines and 
chemokines attract phagocytic cells, monocytes, alveolar macrophages, neutrophils. 
This antigen antibody complex eventually form a nodular granulomatous structure 
called tubercle 
 
 
Figure 4.3 pathogenesis of Mycobacterium tuberculosis 
 
 
 The tubercle enlarges and bacilli drain into local lymph nodes causing 
lymphadenopathy. This lymphadenopathy is the characteristic manifestation of 
primary TB. The lesion thus caused by multiplication of bacilli and further spread to 
lymphatic system causing lymph node enlargement is called Ghon`s complex. 
 
Source: internet www.cdc.org 
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Figure 4.4-Pathogenesis of Mycobacterium tuberculosis 
 
 
Among those exposed to infective individuals, in nearly 90%, bacilli continue to 
proliferate for a period of 2 to 10 weeks following infection until an effective cell 
mediated immune (CMI) response develops. Progressive destruction of the lung 
occurs due to poor CMI response. 
Figure 4.5-Ghon`s complex 
 
Source: internet www.cdc.org 
Source: internet www.CDC.org 
wwwww.cdc.org 
 13 
 
 
If untreated, death ensues in up to 80 % of the cases and the survivors may develop 
chronic disease or recover. Complete  spontaneous eradication of bacilli is rare(20). 
4.1.5 Reactivation disease: 
Proliferation of the latent bacteria causes reactivation TB. It occurs in 5 to 10 % of 
cases during their life time (12). 
Immunosuppressive conditions associated with reactivation TB include HIV infection 
and AIDS, end-stage renal disease, diabetes mellitus, malignant lymphoma, 
corticosteroid use, inhibitors of TNF-alpha and its receptor, diminution in cell-
mediated immunity associated with age, Cigarette smoking(21)(22)(23). 
4.2Burden of TB: 
4.2.1 Global scenario: 
Deaths due to TB shows 1.5 million, majority of the deaths (1.1million) were HIV-
negative people and the rest were (0.4 million) HIV –positive people. In 1990 it was 
the seventh most leading cause of morbidity. The trend is expected to continue till 
2020.In 2001; 1.86 billion persons were infected with tuberculosis according to WHO 
estimates. statistics shows that each year 8.74 million people may get infected with 
tuberculosis and of these nearly 2 million die of the disease(24). 
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As per the statistics it comes to light that someone somewhere gets affected and dies 
of TB every 10 seconds. Hence in 1993, TB is declared as global emergency by the 
WHO. With effective diagnosis and treatment, 37 million people were saved during 
the years 2000- 2013. Reportedly estimated that over 9 million people were affected 
by TB and 1.5million died from disease of which 360,000 were HIV-positive   
(1).Global prevalence of TB infection 32% (year 1999).DOTS (Directly observed 
treatment short course) strategy was established worldwide as a key intervention to 
achieve tuberculosis control worldwide in 1995. The targets of this strategy globally 
are to achieve 70% case detection and 85% cure rates by 2005(25).  
4.2.2 Indian scenario: 
The estimated figure for prevalence is 2.6 million as per 2013 WHO statistics(3). TB 
was declared as a notifiable disease in 2012  May, which means with immediate effect 
all private doctors, caregivers and clinics who involved in treating a TB patient should 
report every case of TB to the government(4). India and China alone contributed to 35 
% of cases reported in 2013. According to Global tuberculosis report-2014 published 
by WHO, 6.1 million TB cases were reported in 2013.Of the reported, 5.7 million 
people were newly diagnosed and 0.4 million were already on treatment(3). 
Prevalence of TB per lakh population has reduced from 465 in the year 1990 to 230 in 
2012(12).  
Mortality per lakh population has reduced from 38 in year 1990 to 22 in 2012 in those 
with TB. In absolute numbers, morality due to TB has reduced from 3.3 lakhs to 2.7 
lakhs annually2012 (26). 
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DOTS program has successfully treated 84% of the registered smear positive cases but 
could detect only 28% of the estimated tuberculosis cases in the world(27). The key 
elements of the TB control program are early diagnosis and prompt effective therapy. 
Delay in diagnosis will eventually result in increased infectivity of the community. It 
is estimated that an untreated patient of smear positive tuberculosis has the potential to 
infection an average 10 contacts annually and over 20 during the natural history of the 
disease until death(14). 
Smear positive cases have high infectivity. In many countries the ministries of health 
has increased the DOTS coverage since 1990`s.However this increased coverage is 
not coupled with effective parallel case detection. Coverage is however crucial, but 
not the only factor for timely access to health services. Studies show that access to 
treatment is hindered by many factors influencing delay in the treatment in TB 
patients. Several factors influence delay in diagnosis and start of treatment, which 
includes individual perception of disease, distance between patient’s residence and 
health services and expertise of the health personnel (5, 6, and 8). 
Delay in diagnosis may lead to more extensive disease and high mortality. Delay 
consequently adds to period of high infectivity in the community (14). 
With the advent of RNTCP Program, early diagnosis and prompt effective therapy is 
at its speed and the treatment centers are decentralized to stick to the policy at its best 
(14). 
Currently detection of TB is done by passive case finding where the patient 
approaches the health facility. At the health facility with high clinical suspicion and 
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laboratory confirmation the disease is diagnosed. This major step requires expertise 
and competency of the health care personnel at the clinical assessment as well as the 
type of diagnostics available and skills of the laboratory personnel. In this complex 
continuum, anything can go wrong at any part of the chain that is involved in 
diagnosing the patient, and the disease remains undetected. This further adds to delay 
in initiation of treatment and leads to further progression and transmission of the 
disease with high infectivity and flared up transmission. Consequently increasing the 
morbidity and mortality as well as transmission(28). 
4.3 Risk factors for transmission: 
The people who are at risk to contract the infection include close contacts with TB, 
those living in crowded conditions, conditions like HIV which weaken the immune 
system, conditions where people require treatment with immunosuppressant like 
corticosteroids, chemotherapy, or tumor necrosis factor (TNF) inhibitors, those that is 
young or old-because their immune system tends to be weaker than those of healthy 
adults (29). 
Also in poor health or poor diet-such as drug misuse, alcohol misuse, or homelessness 
and inhabitants or immigrants who have spent time in country with high levels of 
TB(29). 
The density of population, size of family, crowded localities or living condition, poor 
ventilation favour higher rate of infection and more disease(30). 
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Indiscriminate coughing and spitting by those with the disease will increase the 
bacterial load and pose a threat of vicious cycle in the family. Covering mouth and 
while coughing is an effective method as well as good ventilation may reduce the risk 
of transmission of the disease. Untreated or partially family member is the source of 
infection in many cases(30). 
TB is serious obstacle to sustainable development. TB and poverty are interrelated. 
Burden of the disease on the family increases the expenses for treatment as they 
approach multiple health facilities before the diagnosis, though the DOTS are free of 
cost. Thereby push a family into debts and exacerbating the existing poverty. It 
decreases a person’s work capacity, forming a vicious circle.80% of the patients are in 
economically productive age group(15-44years), the economic and social cost to them 
is huge(17). 
4.4 TB and its economic impact: 
TB costs Rs. 12000 crore annually to India. Approximately 300,000 school drop outs 
due to parents TB are other non-disease costs of TB. The cost to patient as he 
approaches different health facilities before reaching the diagnosis and successful 
treatment averages US$ 100-150, more than half of income of daily wage laborer. On 
an average 3 month of work time is lost if an adult has TB; resulting in loss of 20-30% 
of annual household income. If a patient dies from disease an average of 15 years of 
income is lost(3). 
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4.4.1 Indirect cost to society: 
US$3 billion per year, direct cost US$ 300 million. 100 million productive workdays 
per year are lost due to illness alone. India loses more than 13 billion productive days 
due to TB deaths. More than 100000 women are rejected by their families on account 
of TB. 
The patient with TB, with sputum smears positive acts as a reservoir as well as source 
of infection for tuberculosis. Disease burden of bacillary cases in India is over 3.8 
million and every year we detect 1 million smear positive cases(30). 
4.5 Mortality from tuberculosis in India: 
With advent of DOTS, mortality rate has declined to 23 per 100000 in 2010 from a 
rate of 42 per 100000 in 1990, thus reducing the mortality rate by 55%. However in 
sputum positive cases mortality has decreased 7-fold (from 29% to 4%) (17). 
TB patient with HIV infection have more chances of deaths (14% against less than 4% 
in HIV negative TB cases and development of multi drug resistant TB. 
Under RNTCP diagnosis and treatment of TB is free of cost. Under RNTCP diagnosis 
and treatment of TB is free of cost.(31) DOTS increased coverage in several health 
facilities in several countries since 1990s, however there are still gaps in the diagnosis 
as well as initiation of treatment. 
 Multiple factors were identified to contribute to the delay in both diagnosis as well as 
initiation of TB treatment. The individual perception of the disease, socio economic 
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level, stigma, lack of awareness of the disease, severity of the disease, distance 
between the nearest health facility and the patient`s residence are few of the listed 
factors for delay as shown by various studies. There are challenges involved in 
identifying the factors involved. Delay may occur at any level, the delay for a patient 
to reach a health facility is called patient delay, and delay in diagnosis of TB at the 
health facility is health system delay. Delay in case finding is studied in many 
countries, in low prevalence countries delay is either attributed to disintegration of the 
previous TB infrastructure for TB control or the disease is not suspected of TB (19-
22). 
 Longer delays were noticed in high prevalent countries. This delay was either due to 
patients in approaching health care or physicians delay in diagnosis. Reported 
determinants of delay include being part of specific patient groups (i.e. women, rural 
versus urban residents, nationality, etc.) (20), either availability of the health providers 
or accessibility to health services (20-21). 
These studies show the association between delay and an increased economic burden 
and also mortality attributed to tuberculosis. In order improve quality of RNTCP 
country-specific determinants of delay must be studied and addressed. 
4.6 Knowledge and health seeking behaviour on tuberculosis: 
In a cross-sectional study done in the Ilala District hospital, Tanzania on consecutive 
patients with pulmonary tuberculosis (TB) symptoms and who attended the clinic for 
medication; health seeking behaviour of the infected was affected. Over half of the 
patients (54.3%) said that they openly speak about illness to others, but 36.3% said 
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that their family and friends became less friendly. Others were discriminated even 
after starting DOTS. This further delays the control of disease(32). 
 
The commonest contact was another family member. People with poor recall ability 
masked the history of TB contacts and lack of knowledge of TB status is noticed 
among study population. (32). 
Risk of infection is high among the close contacts(33). The close contacts usually 
were family members. The transmission of TB generally occurs indoor, where droplet 
nuclei stay in the air for a long time (4). In a study in Bangkok, Thailand, the 
prevalence of TB among households contact was 47.08% (34). This confirms the 
existence of knowledge that TB transmission is associated with environmental factors 
(32, 33). 
 
A WHO study was done on seven countries of the eastern Mediterranean region on the 
health seeking behaviour of patients and health system response. The study was 
conducted during the period of 2003-2004. Among the countries which were included, 
in Pakistan the study was conducted in DOTS centers. In Iraq it was conducted in 
respiratory and chest diseases institute and 3 other tuberculosis centers. In Somalia a 
convenient sample was chosen from accessible centers of DOTS. In other countries 
nation-wide cross sectional studies were conducted(35). 
The age group of the study population is taken as 15 years and above. All newly 
diagnosed smear positive cases are included in the study with estimated incidence for 
tuberculosis least reliable sample size calculated was 5053 patients; data collected 
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using clustered random sampling technique. A positive history of previous exposure 
to a tuberculosis patient was recorded in 12%–20% of patients in Syrian Arab 
Republic, Egypt and Yemen, in more than one-third of patients in the Islamic 
Republic of Iran, almost half of the patients in Somalia. In 93.4% of patients in 
Pakistan, the main symptom that prompted the patients to seek health care was cough 
with or without fever(35). 
Social isolation and stigmatization were overall manifest in each gender’s perception 
about tuberculosis as an illness. In Iraq, the degree of stigma was high (89.8%) for 
most tuberculosis patients(38).The main source of information about tuberculosis was 
friends/relatives (44.6%) as well as other tuberculosis patients (51.9%)(35).  
 
In Pakistan, self-medication (50%), only 25 visited health care provider. However, 
when the symptoms did not subside then the number increased to 239 patients. On 
repetition of the symptoms next choice of preference was (33.5%) a traditional healer.  
During the third time when the symptoms did not subside, but a higher percentage 
(66.1%) also consulted a health care provider. 
 
Most patients incurred heavy expenditures before the diagnosis of tuberculosis was 
made. The median expenditure incurred was US$ 17.1 with a mean of US$ 18.6         
(±14.62). In Pakistan (96.3% of cases) visited private clinic with the advent of 
symptoms. 
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4.7 Reasons for delay in diagnosis from various studies: 
The mean duration of delay between the onset of symptoms and treatment ranged 
from 46 days in Iraq to 127 in the Islamic Republic of Iran.  
Patient delay in the Syrian Arab Republic was significantly associated with inadequate 
knowledge (AOR-1.07; 95% CI 1.01–1.14), seeking health care from a traditional 
healer, (AOR 5.66; 95% CI 3.02–10.62), and seeking care from more than one health 
care provider (AOR 1.20; 95% CI 1.02–1.40).In Yemen the significant risk factors for 
patient delay were: female sex (AOR 2.03; 95% CI1.1–3.6) and inadequate knowledge 
regarding the disease (AOR 1.1; 95% CI 1.04–1.2) for each unit of poor knowledge.  
 
The fatalistic attitude of patients i.e. (60.5%) patients felt that the illness would cure 
itself. Financial issues (16%) played a crucial role in delay in patients. Other reasons 
were economic constraint, fear of diagnosis and social isolation (stigma) and 
perceived poor quality of health services or inadequate staff attitude.  
 
4.7.1 Risk factors of health system delay  
The WHO study on seven countries of the eastern Mediterranean region also revealed 
that older age positive history of chronic pulmonary disease and seeking initial care 
from the private sector were risk factors for health system delay(AOR 1.001; 95% CI 
1.003–1.007, AOR1.3; 95% CI 1.2–1.5andAOR 1.2; 95% CI 1.1–1.3 
respectively)(32).  
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In Tanzania, a longer health care system delay was seen when patients, especially in 
rural areas, consulted traditional healers (36).In Gambia, patients who initially 
consulted health care providers had a shorter delay compared to patients who initially 
consulted alternate healers (37).In Nepal longer patient delay in women was 
contributed to by consultation with traditional healers and more frequent visits to 
health care providers before final consultation with the NTP (38). 
 
 
A significant difference was seen in initiation of treatment after diagnosis between 
private health care providers and tuberculosis centers. When a patient was diagnosed 
by a tuberculosis centre a median of 2 days and mean of 33 days was seen between 
diagnosis and initiation of treatment. However when private practitioners diagnosed a 
case of tuberculosis they took a very long time to initiate treatment (median 10 days; 
mean 98 days) (32).  
 
Lower income or the long distance to reach the health care providers prompted the 
patients to either try self-medication (50%) or consult a pharmacy (42.2%) as the first 
action after symptoms in Pakistan (32).  
 
In Egypt the significant factors were: being illiterate (2.76 fold increased risk); time to 
reach health facility >1/2 hour and>1 hour (1.73 and 1.75 fold increased risk 
compared to those ≤1/2 hours); high crowding index (1.2 fold); and more than one 
health care provider before diagnosis (2.55 fold increased risk)(32).In most of the 
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health centers patients were not satisfied with the health care facilities and consulted 
the alternate methods of treatment providers including homeopaths (32) 
 
The significant risk factors for patient delay that were frequently reported from the 
studied countries were living in suburbs and rural areas, inadequate knowledge 
regarding tuberculosis, a high degree of stigma, inadequate satisfaction with care, 
seeking health care from a non-specialized individual at onset of symptoms, and 
seeking care from more than one health care provider. 
 
A study from India showed that tuberculosis patients on an average visited 2.5 doctors 
before reaching the NTP (39).The delay reported from Pakistan was comparable to the 
rates reported from Viet Nam, i.e. a mean of 69.3 days and median of 44.1 (40). 
 
 The mean duration between the onset of symptoms and treatment was 46 days in Iraq, 
57 in Egypt, 59.2 in Yemen, 79.5 in Somalia, 80.4 in Syrian Arab Republic, 100 in 
Pakistan, and 127 in Islamic Republic of Iran. Various mean delay durations were 
reported from different endemic countries: 60 days from India, 87.5 days from 
Malaysia, and a median delay of 99 days from Nepal (35-37). 
 
 Socio demographic characteristics proved to be significant predictors of delay in 
almost all countries. Age above 35 years was associated with a 1.01–1.7 fold 
increased risk per year in Syrian Arab Republic, Islamic Republic of Iran and Iraq. 
Female gender was associated with an increased risk for delay in Yemen but was 
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protective in Egypt, prompting patients to seek timely health care. Illiteracy and 
overcrowding were also significant risk factors in Egypt and Iraq, respectively.  
Residence proved to be a significant risk factor for delay in Iraq, Somalia, and 
Pakistan where living in suburban areas was associated with a 3, 2.2 and 2.5-fold 
increased risk for delay in treatment, respectively, compared to urban areas(32).  
 
The study done in health facilities in four districts in South India to investigate risk 
factors for patient and health system delays among new smear-positive tuberculosis 
patients contain health facilities that served urban, semi-urban and rural populations. 
At each of the selected health facilities, all new smear-positive pulmonary tuberculosis 
patients aged 15 years diagnosed during the preceding month and subsequently 
undergoing treatment were considered eligible for the study. Cases diagnosed only on 
the basis of X-ray and those with previous history of treatment were excluded. 
 
Among 531 participants, the median patient delay was 20 days, health system delay 
was 23 days and total delay was 60 days. Among the 29% of patients who delayed 
seeking care for 1 month, 40% attributed their delay due to lack of awareness about 
TB. Men delayed seeking care than women (P 0.07). In multivariate analysis, if the 
patient had initially consulted a government provider (adjusted odds ratio [AOR] 2.2, 
p value 0.001) the delay was more. Residency at a distance 2 km from a health facility 
(AOR1.6, P 0.04), and was an alcoholic (AOR 1.6, P 0.04) also caused more than. 
Health system delay was 7 days among 69% of patients (36). 
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First consultation with a private provider (AOR 4.0, P 0.001), a shorter duration of 
cough (AOR 2.6, P 0.001), alcoholism (P 0.04) and patient’s residence 2 km from a 
health facility (AOR 1.8, P 0.02). The total delay resulted largely from a long patient 
delay when government providers were consulted first and a long health system delay 
when private providers were consulted first. 
Public awareness about chest symptoms and the availability of free diagnostic services 
should be increased. Government and private physicians should be educated to be 
aware about the possibility of tuberculosis when examining out-patients. 
Effective referrals for smear microscopy should be developed between private and 
public providers(39). 
 
In conclusion, patient delay is mainly dependent upon the health-seeking behaviour of 
tuberculosis patients which is mainly determined by their socio demographic 
characteristics, place of first consultation and degree of stigma felt and knowledge 
regarding the disease (32). 
 
4.8 Stigma associated with TB: 
In the study done in Zambia TB is reported as a contagious disease in 57% of 
respondents (36). Of the total respondents 75.6% knew that TB is curable (38). 
Many of them wanted to live in isolation (self-discrimination) which may be due to 
fear of transmitting TB, and avoiding gossip and potential discrimination. This 
attributes to 42.9% of men and 36.9% of women and they strongly agreed with this 
idea (41).  
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A study from Dharan, India also depicted that stigma and treatment outcome and 
delay in seeking care were associated (42). 
High degree of stigma was protective (AOR = 0.64 (0.51–0.82)), in that the high 
degree of stigma attached to tuberculosis by some patients is presumed to have 
motivated them to seek health care earlier than others (32). 
In Pakistan, 37.9% 0f the patients in the study evidently showed that fear of diagnosis 
is one of the reasons for delay in reaching TB clinics. Stigma attached to the disease is 
expressed a fear of social isolation if diagnosed with tuberculosis by 18.1% of patients 
disease. One of the co-authors from the previous study done in Pakistan also 
documented that stigma has a major role in determining the health-seeking behaviour 
of patients(43),(44). 
The efforts to combat TB were severely affected for stigma being one of the 
reason(7). There is vast literature available to understand available to understand the 
factors related or affecting delay in the health seeking behaviour which reflects on 
early diagnosis and initiation of the treatment in TB patients(8). Apart from socio 
economic status, knowledge about TB, smoking and other personal characteristics; 
psychosocial factors also play an important role in the diagnosis of TB(9). The psycho 
social factors include stigma in the case TB, which may cause rejection, shame, 
blame, exclusion from those of healthy individuals(10). There is a great evidence from 
various  studies which suggest that stigma associated with TB could be a reason in 
delay in seeking health care in TB patients(11).one of the factor highlighted from 
other studies was many of the patients had the fear that their disease would be labelled 
as related to AIDS (12).  
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4. Methodology: 
5.1 study setting 
Community Health Department and Development Hospital (CHAD): 
The Department of Community Health, Christian Medical College, Vellore, India, has 
been working in Kaniyambadi and Anaicut Blocks and urban parts of Vellore for the 
past 50 years. The Community Health and Development (CHAD) Program is run by the 
Department of Community Health. Along with the government health services, it 
provides primary health care including maternal and child health services, screening 
and treatment for communicable and non-communicable diseases. CHAD program 
along with government runs RNTCP program as a Tuberculosis Unit, Tribal health 
program and school health program.  CHAD program runs mobile clinics offering 
preventive and curative services in each village every month in Kaniyambadi block, 
parts of Vellore urban and Tribal area (Jawadhi Hills). These areas have grass root 
workers at the village level that identifies people with medical problems and also 
function as DOTS providers. Patients who cannot be treated are referred to the base 
hospital which offers secondary care services. If tertiary care is needed, patients are 
further referred to the Christian Medical College and Hospital, where specialty care 
and advanced laboratory services are available. 
CHAD Hospital is situated at the outskirts of Vellore town. It is a 135 bedded 
secondary care hospital and primary referral centre for its distinct outreach activity in 
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the rural block of Kaniyambadi. CHAD as a Non-governmental Organisation (NGO) 
runs TB unit under public private mix scheme in RNTCP. CHAD TB unit caters to  
Kaniyambadi block, Anaicut block, Alangayam block and a part of urban. In 2003 
CHAD was recognized as a nodal centre for south zone for the RNTCP. The TB  unit 
of CHAD coordinates the TB activities nearly 15 peripheral centres including Vellore 
Government Medical College, Narayani Hospital and primary health centres serving 
6,50,00 population.  
5.2 Study design: 
The present study was a cross-sectional study to understand the factors related to 
delay in diagnosis and initiation of treatment in newly diagnosed sputum positive 
tuberculosis patients. 
5.3 Study participants: 
All new sputum positive patients enrolled in various health facilities under CHAD-TU 
who were diagnosed during November 2014 to May 2015 were included in the study. 
Temporary residents were excluded from the study.  
For the community study among general population, people above 18 years from 
Kaniyambadi block were included. Only permanent residences were selected.  
5.4 Sampling technique: 
As the number of new sputum patients registered every month is around 40 in this TU, 
all participants who were above 18 years of age and willing to be visited by the 
investigator within 4 weeks of staring treatment were selected.  
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To study the community’s perspective stigma towards TB, 10 villages were randomly 
selected from Kaniyambai block and from each of these 10 villages, 10 people were 
randomly selected (two stage sampling). Total of 100 people from general population 
were interviewed after getting consent. None of the selected participant refused to 
participate in this study.  
5.5 Sample size calculation: 
A multi-centric study by WHO showed that the median time delay was between 44 
days to 97 days in different countries. The mean delay in Pakistan was 100.7 days (SD 
34.2) (6).  Using the formula N=4SD
2
/d
2
, (with the SD of 34.2 and a d of 7 days), the 
estimated desired sample size was 95.  
For objective 3, to assess perception of stigma among general population, assuming 
that 50% will have adequate knowledge on TB, 100 people were included. 
5.6 Data collection: 
During the study period, 128 patients were registered under the CHAD TU. The 
details of the study participants were obtained from the TB registers as well as by 
visiting the government health centres that were under the CHAD-TU. All these 
patients were contacted through telephone or through the DOTS provider/STS and 
obtained their oral permission to visit them. Those who gave permission were visited 
at their residence or at the health centres or any place of their convenience.  
The investigator could meet only 97 people as 3 people died within the first 2 weeks 
and others could not be approached within 4 weeks of starting treatment. As 2 people 
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did not give consent, only 95 were interviewed. The time limit to interview the 
participants with TB was taken as 4 weeks in order to minimize the recall bias. The 
following is the flow chart depicting the method of data collection: 
 
 
All new patients with pulmonary TB registering between November 
2014 to May 2015 data is obtained from TB registers (128) 
Eligible participant were contacted through phone/DOTS provider/STS 
officer for permission to meet (97) 
Eligible  participants were met at the clinic/ House /place of 
convenience within 2 weeks of diagnosis (97) 
Informed consent was taken and included into the study (95, 2 refused) 
Directly interviewed using structured questionnaire 
Data entered using  Epi-data and analysis  was done using SPSS 
 
During the data collection 3 patients were reported to be dead and 28 people 
could not be contacted within 4 weeks of treatment. 
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For objective 3, to study the community’s perception regarding stigma 
towards TB and their awareness:   
                  Study area: Kaniyambadi block 
    
  Randomly selected 10 villages 
        
  Randomly selected 10 people from each village 
 
  Informed consent obtained 
 
  Interviewed using structured questionnaire  
 
  Data entry and analysis 
 
5.7 Study tools: 
A structured questionnaire was used to collect information. The questionnaire was 
translated into Tamil (the local language) and back translated into English and pilot 
tested.  
The questionnaire had the following section: socio-demographic details, personal 
habits like alcohol and smoking, monthly income and debt due to medical treatment, 
knowledge on symptoms, modes of transmission, method of diagnosis, treatment 
(duration and follow up) and cure. Participants with TB had another section with 
questions on their treatment seeking pattern for symptoms suggestive of TB, time gap 
between the onset of symptom to seeking medical help to diagnosis and initiation of 
treatment. 
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Validated TB Stigma Scales developed by Van Rie et al., (2008) was used to measure 
stigma related to TB. Variables measuring stigma were coded a 4-point Likert scale 
with the following levels: ‘0’ as strongly disagree, ‘1’ as disagree, ‘2’ as agree, and ‘3’ 
as strongly agree.  
5.8 Informed consent: 
After getting oral consent, the investigator visited the participants and an information 
sheet (in Tamil) was given to them explaining the purpose of the study, voluntary 
nature of participation and confidentiality of the concerns and the disease. Participant 
was verbally explained in their own language and further queries were clarified. Then 
written consent was taken with their willingness to participate in the present study. 
The health status of the participants with TB was checked and they were encouraged 
to be take regular treatment. 
5.9 Study variables 
The main outcome variables were delay in diagnosis and treatment, knowledge on 
tuberculosis (symptoms, modes of transmission, treatment and follow up) and 
perceived stigma related to TB. 
Delay is the main outcome. Delay can be divided into 2 components – patient delay 
and health system delay. It can also be divided into diagnostic delay and treatment 
delay.  
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Figure 4.6 Different categories of delay; and their contribution to total delay 
 
 
 
Stigma: As measured by the validated scale which was developed by Van Rie et al. in 
2008. This scale used a 4-point Likert scale with the codes of ‘0’ for strongly disagree, 
‘1’ for disagree, ‘2’ for agree, and ‘3’ for strongly agree. Higher scores were related to 
higher stigma. This scale has 2 components –The perception of people living with TB 
about how community perceive or feel about Tuberculosis (Community Tuberculosis 
Stigma Perception with11 items), the perception of people living with TB about how 
Patients perceive or feel about TB (Patients’ Stigma Perception with 12 items).  
Determinants of delay and stigma: Socio-demographic variables like age, gender, 
education, occupation, type of house, type of family and economic status of the 
family.  
5.10 Data management and analysis: 
Data collected was entered in epidata 3.1 and analysis was done using SPSS 16. 
Descriptive statistics of the socio-demographic variables was done. 
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Mean and median delay in days (patient delay and health system delay) was 
calculated. Using appropriate standards, study group was dichotomized into people 
with delay and without delay with a cut off of 30 days.  
Various determinants of delay were re-coded into binary variables and chi-square and 
p-value was calculated. Univariate and multivariate analysis was done to see the 
association between the determinants and the delay. 
Knowledge and stigma was given scores and total score was computed. Mean scores 
was calculated. Knowledge and stigma scores were dichotomized as people with 
adequate knowledge/ inadequate knowledge and people who have perceived 
stigma/no stigma. 
 Association between knowledge and delay, perceived stigma and delay was studied 
using chi-square tests and regression analysis.  
Knowledge between people with TB and without TB was compared using difference 
in means and by chi-square test (between dichotomized groups). Similarly, perceived 
stigma between people with TB and without TB was compared using difference in 
means and by chi-square test (between dichotomized groups). 
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6. Results 
The study population consisted of both men and women of 18 years and above age 
group. The study aimed at assessing the factors related to delay in diagnosis and delay 
in initiation of treatment in a newly diagnosed sputum positive patient.  
The total number of patients who were interviewed for the study was 95. Among the 
general population 100 people from Kaniyambadi village were interviewed to assess 
the stigma related to tuberculosis (TB).  
6.1 SOCIO DEMOGRAPHIC CHARACTERISTICS: 
6.1.1 Age and gender distribution of the patients and general population: 
The total number of newly sputum positive TB patients who gave consent was 95. Of 
these 52.6% (52) of the patients belong to age group 36-60 years of age group, 26.3% 
(25) were of 18-35 years age group and 21.6% (20) were more than 60 years of age 
(Figure 6.1). 
Figure 6.1Distribution by age 
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Among the general population 39% belonged to age group of 60 years and above, 
38% belong to 36-60 years and 54% of those interviewed were women (Figure 6.1).  
Majority of the study participants were men; 74.7% among participants with Tb and 
71.5% in the general community (Figure 6.2).  
Figure 6.2Distribution by gender 
  
Among the participants with TB, 94.7% (90) were from rural area and only 5 patient’s 
i.e. 5.3% were from urban area (Figure 6.3). All the study participants among general 
population are from rural area (Kaniyambadi block) 
Figure 6.3 Distribution by place of residence among participants with TB 
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6.2 Distribution of educational status of the study population: 
Among the study patients 34.8% (33) had education up to high school, where as 
almost equal proportion of 35.8% (34) were illiterate, only 9.5% (9) of them had 
education up to college and above (Figure 6.4).  
Among general participants only 37% were educated up to high school and 5% has up 
to college (Figure 6.4).  
Figure 6.4 Distribution by educational status of the study population 
 
 
6.3 Distribution of the study population according to marital status 
Among the interviewed 81.1% of the participants with TB and 96% among general 
population were currently married (Figure 6.5). 
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Figure 6.5 Distribution of the study population according to marital status 
 
 
6.4 Distribution according to the type of house and number of rooms 
The proportion of the patients who live in terraced houses was 43.2% (41) as 
compared to 11.6% (11) who lived in huts (Table 6.1). Only one of the patients 
interviewed was homeless. Among the general population 60% of them lived in 
terraced houses. 
Table 6.1 Distribution by housing and number of rooms in the house 
HOUSING Categories Participants with TB 
(n=95) 
General population 
(N=100) 
N % N& % 
Type of 
house 
Hut 11 11.6 4 
Thatched 25 26.3 18 
Tiled 17 17.9 18 
Terraced 41 43.2 60 
Homeless 1 1.1 0 
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With respect to number of rooms 41% (49) were living in more than 2 roomed houses 
as compared to 25.3% (24) living in one roomed houses. 58% among general 
population were living in more than 2 roomed houses (Figure 6.6). 
 
Figure 6.6 Number of rooms in participants’ house 
  
 
6.5 Distribution of the study group by occupation, socio economic status 
Unskilled and daily wage labourers constituted 29.5% (28) among participants with 
TB and 14% among general community. The people with regular salaried jobs were 
23.1% (22) and 7% respectively among people with TB and others. Unemployed 
people were 15.8% (15) and 14% among people with TB and others. Among Only 
7.4% (7) were house wives alone. Majority of those interviewed among general 
population were house wives of 35% (Table 6.2). 
  
24, 22% 
35, 33% 
49, 45% 
participants with TB 
one room
2 rooms
>2 rooms
10, 23% 
32, 74% 
1.4, 3% 
General community 
One room
2 rooms
>2 rooms
 41 
 
Table: 6.2 Distribution of the study group by occupation 
Occupation prior to 
illness 
Participants 
with TB 
(n=95) 
Participants from 
community  
(n=100) 
N % N & % 
House wife alone 7 7.4 35 
Unemployed 15 15.8 14 
Unskilled daily wage 28 29.5 16 
Farming/business/mason 14 14.7 18 
Salaried 22 23.1 7 
Retired 5 5.3 10 
Students 4 4.2 0 
 
 
6.6 Distribution of study population by socio economic status: 
Socio economic status is calculated by Modified Kuppuswamy socio economic scale 
2012. Majority (66.3%) of the participants with TB (63) belonged to upper lower class 
and only 5.3% were from lower class. Similarly 49% of general population 
interviewed belongs to upper lower class (Table 6.3). 
Table 6.3 Distribution of the study group by socio economic status 
 
Socioeconomic 
status 
Participants with 
TB (n=95) 
 
Participants from 
community (n=100) 
N % N & % 
Lower 5 5.3 7 
Upper lower 63 66.3 49 
Lower middle 23 24.2 32 
Upper middle 4 4.2 12 
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6.6 Distribution of the participants by monthly income: 
As given in Table 6.4, current income of the participant with TB per month is 2776 
(95% CI 1974-3598) whereas prior to illness it was 4445 (95% CI 3525-5364). 
Current family income per month is 5039 (95% CI 4202-5876) but prior to illness it 
was Rs.6650 (95% CI 5678-7622). Among the participants without TB monthly 
income was Rs.3682 (95% CI 2660-4704). 
Table 6.4 Distribution of the participants by monthly income: 
Monthly income categories Mean 95%CI 
Income of participants with TB Prior to illness 4445 3525-5364 
Current income 2776 1974-3598 
Family income of participants with 
TB 
Prior to illness 6650 5678-7622 
Current income 5039 4202-5876 
Income of participants without TB Current income 3682 2660 – 4704 
 
6.2 Personal habits: 
6.2.1 Distribution of study participants by tobacco smoking: 
The proportion of the participants with TB who were current smoking was 45.3% (43) 
as compared to 9% in the general population (Table 6.5). Among the smoker’s i.e. 
current smokers as well as ex-smokers 38.8% of them consumes 11-20 
cigarettes/beedi per day. Duration of smoking as told by the patients was 15-29 years 
in 32.7% of the smokers and more than 30 years above on 30.7% of them. In the 
general population majority of them (84%) were never smokers. 
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Table 6.5 Distribution of study participants by tobacco smoking 
Smoking Categories  Participants with TB 
(n=95) 
Participants from 
community  
(n=100) 
N % N & % 
Smoking status Never 43 42.3 84 (84) 
Current 43 45.3 9 (9) 
Ex-smoker 9 9.5 7 (7) 
Daily consumption 
(number per day) 
n=52 
Upto 10 20 38.5 8 (50.0) 
11-20/ 20 38.5 4 (25) 
21-50 7 13.5 3 (18.8) 
>50 5 9.6 1 (6.2) 
Duration of 
smoking n = 52 
<15 years 12 23.1 3 (18.8) 
15-29 years 17 32.7 4 (25) 
30 years and 
more 
16 30.7 9 (56.28) 
 
6.2.2 Distribution of study participants by their personal habits (alcohol 
consumption)  
The proportion of participants with TB who never consumed alcohol was 3.7% (51), 
but 38.9% (37) of them were currently consuming alcohol (table 6.6). Among those 
who ever took alcohol i.e. current alcohol abusers as well as those in the past (44), 
31.8% consumed up to 500ml of alcohol per day.20.5% (9) of them consumed more 
than 2 litres of alcohol, which was mostly a local brand. Among the alcohol 
consumers, 29.6% (13) took it at least 2 to 3 times per day. Among the general 
population, only 4% were current alcohol users (Table 6.6).  
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Table 6.6 Distribution of study participants by their alcohol consumption 
                                                             
Alcohol consumption                               
Participants TB General 
population 
N                   % N % % 
Alcohol intake Never 51 53.7 89 
Current 37 38.9 4 
Past  7 7.4 7 
Daily 
consumption 
Upto 500 ml 14 31.8 6 (54.6) 
501 - 1000 ml 13 29.6 3 (27.3) 
>1001 - 2000 
ml 
8 18.1 2 (18.2) 
>2000 ml 9 20.5  
Frequency of 
alcohol intake per 
week 
Upto 2 times  12 27.3 6 (54.6) 
3-6 time 13 29.6 1 (9.1) 
Daily 19 43.1 4 (36.4) 
 
In the general population 89% of the interviewees never consumed alcohol, only 11 of 
them gives history of alcohol abuse either in the past or at the present. Among these 
11, 54.6% i.e.6 of them were consuming up to 500ml per day with frequency of 2 to 3 
times per week. 
6.3 History of TB among the study participants 
Among the 95 patients interviewed 4.2% gave previous history of treatment for TB 
and 16.8% gave family history of TB in the general population 3% had previous 
history of TB and 3% gave family history of TB. 
6.4 Symptoms experienced by the patients before they were diagnosed 
Among the newly diagnosed sputum positive patients 93.7% (89) had cough as the 
symptom, 85.3% (81) also had fever. The proportion of patients who had loss of 
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weight was 84.2% (80) and loss of appetite was 83.2% (79). Only 22.1% (29) gave 
history of haemoptysis ( Table 6.7). 
Table 6.7 Symptoms experienced by the patients before diagnosis 
Symptom N % 
Cough 89 93.7 
Fever 81 85.3 
Loss of weight 80 84.2 
Loss of appetite 79 83.2 
Haemoptysis 21 22.1 
Chest pain 18 18.9 
 
6.5 Symptom for which the treatment is sought  
Majority of them i.e. 40% sought treatment for cough, 28.4% of them sought the 
treatment as they had fever as their main symptom (Table 6.8). 
Table 6.8 Symptom for which the treatment is sought 
 
 
 
 
6.2.6 Health care seeking behaviour with onset of illness 
 With the onset of illness 43.2% sought treatment from private hospitals, apart from 
this 29.5% of them used self-medication. Only 12.6% 0f them approached PHC`s with 
the onset of illness and 1.1% to Government Vellore Medical College, (GVMV) 
which is a higher government referral centre (Table 6.9). 
Symptoms  N % 
Cough 38 40 
Fever 28 28.4 
Loss of weight 5 5.3 
Breathlessness  4 4.2 
Haemoptysis 5 5.3 
Chest pain 8 8.4 
Others 8 8.4 
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Table 6.9 Health care seeking behaviour with onset of illness 
 
 
 
 
 
 
 
6.2.7 Health care facility from where patient first sought treatment 
Private hospital is the first approached health facility by 64.2% of the patients, though 
20% of them visited PHC`s for the treatment (Table 6.10). 
Table 6.10 Health care facility from where patient first sought treatment 
 
 
 
 
 
6.5.1 Health care providers who made initial diagnosis: 
The initial diagnosis of TB was made by GVMC for a proportion of 35.8% and 32.6% 
of the patients were diagnosed in CHAD (Table 6.11). 
 
 
Health facilities N % 
Self- medication 28 29.5 
Traditional 
medicine 
1 1.1 
Chemist shop 7 7.4 
PHC 12 12.6 
GH/CHC 2 2.1 
GVMC 1 1.1 
CHAD 3 3.2 
CMCH 0 0 
Private hospital 41 43.2 
Health facility N % 
Primary Health Centre 19 20 
Government Hospital /Community Health 
Centre 
3 3.2 
Government Vellore Medical College 3 3.2 
CHAD hospital 8 8.4 
CMC Hospital 1 1.1 
Private hospital 61 64.2 
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Table 6.11 Health care providers who made initial diagnosis: 
 
 
 
 
 
6.5.2 Expenditure related to TB care: 
Money spent on approaching health providers for treatment (both direct and in direct 
costs) was counted. Total cost before diagnosis spent by 38.9% of them was up to 
Rs.500; only 2 of them spent money of more than Rs.50, 000 before diagnosis (Table 
6.12).  
Table 6.12 Expenditure related to TB care 
Total cost before diagnosis (in 
RS.). 
No % 
Upto 500 37 38.9 
501-1000 13 13.7 
1001-5000 25 26 
5001-10000 7 7.4 
10001-50000 13 13.8 
>50000 2 2.1 
 
6.5.3 Debts due to medical expenses (Rs.) 
Out of the interviewed, 58.9% of them did not have any debts due to medical 
expenses, but 21.1% of them had debts in the range of Rs. 10001 to 50000. 
 
 
Health facilities N % 
Primary Health Centre 5 5.3 
Government Hospital /Community Health 
Centre 
11 11.6 
Government Vellore Medical College 34 35.8 
CHAD hospital 31 32.6 
CMC Hospital 4 4.2 
Private hospital 10 10.5 
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6.5.4 Reasons for choosing the particular provider 
Of the interviewed 62.1% said that they choose the particular provider as it was 
accessible for them; 31% of them has chosen as they had confidence in the particular 
provider of their choice (Figure 6.7). 
Figure 6.7 Reasons for choosing the particular provider: 
 
6.5.5 Action/investigations done in the health facility: 
Sputum examination is done in 98.9% of the patients interviewed, blood tests were 
done in 96.8% of them where as 88.4% of them also had chest x-rays taken 
(Table 6.13) 
Table 6.13 Action/investigations done in the health facility: 
                   Investigation        N        % 
                   Sputum test       94       98.9 
                   Blood test       92       96.8 
                   X-ray       84       88.4 
 
59, 63% 
30, 32% 
1, 1% 
2, 2% 
2, 2% 
Reasons for choosing health 
provider 
accessible
confidence
availability
free
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6.5.6 Reasons for not going to CHAD/CMC/GVMC/PHC which are microscopic 
centres) 
The proportion of patient`s who thought it is not necessary to go to these centres 
attributed to 47.4% where as 27.4% of them couldn’t go as they have no money. 
Among those who 16 (16.8%) gave others as the reason; 9 of them have immediately 
approached their regular health provider and waited to be cured of the sickness until 
they were diagnosed of TB. 
6.14 Reasons for not going to CHAD/CMC/GVMC/PHC: 
Reasons N=95 % 
Thought not necessary 45 47.4 
Too far 2 2.1 
Long waiting time/ too 
busy 
3 3.2 
Previous bad experience 3 3.2 
No money 26 27.4 
Others 16 16.8 
 
6.5.7 Time delay in diagnosis (number of days) 
The proportion of patients who experienced a delay of 91-180 days was 26.3% and 
24.2% of them experienced a delay of 31-90 days in diagnosis of the disease (Table 
6.15). 
Among those who had delayed 67.4% responded that they considered it as delay. 
        Table 6.15 Time delay in diagnosis (number of days) 
Time delay in diagnosis Days     N     % 
No delay/<2weeks 10 10.5 
15-30 23 24.2 
31-90 30 31.6 
91-180 25 26.3 
>180 7 7.4 
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6.5.8 Reasons by patients for delay 
Among the 64(67.4%) who considered it as delay, 53.1% responded that they delayed 
hoping that symptoms would subside. The proportion of patients who delayed due to 
economic constraints was 17.2% (11), only 7.8% delayed due to fear of diagnosis 
(Table 6.16). 
Table 6.16 Reasons by Participants with TB for delay in reaching health centre 
Reasons  (n=64) N % 
Fear of diagnosis 5 7.8 
hoped that symptom will subside 34 53.1 
Fear of social isolation 1 1.6 
Economic constraints 11 17.2 
unsatisfied staff attitude 2 3.1 
Poor quality of health services 4 6.3 
Others 7 10.9 
 
6.5.9 Reasons for delay in seeking care in other people in the community who has 
similar complaints 
When asked about the reasons as perceived by the patient among those who had the 
similar complaints in the community, 51.6% said that they do not have money was the 
reason for their delay. 28.4% of them said they did not approach as they felt it was not 
necessary to seek health care (Table 6.17). 
Table 6.17 Reasons for delay in seeking care in other people in the community 
who has similar complaints 
Reasons  N % 
Not necessary 27 28.4 
Too busy 6 6.3 
Bad experience 4 4.2 
No money 49 51.6 
Don't know 9 9.5 
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6.5.10 Mean patient delay 
The time taken by the patient to approach health facility for treatment with the onset 
of symptom is taken as patient delay. The mean patient delay was 38.5 days with 
range of 2 days to 540 days with 95% CI of 25.3-51.6 (Table 6.18). 
Table 6.18 patient delay 
Type of delay Mean 95%CI Median min Max 
Patient delay in reaching health 
facility for diagnosis 
38.5 25.3-51.6 20 2 540 
 
6.5.11 Mean health system delay 
The time taken from the onset of symptoms to diagnosis of the disease is health 
system delay. In the present study the mean health system delay in diagnosing was 
99.3 days (95% CI 79.5-119.1) and range from 3 to 547 days (Table 6.19). 
Table 6.19 Health system delay 
Type of delay Mean 95%CI Median min Max 
Health system delay in 
diagnosing 
99.3 79.5-
119.1 
90 3 547 
 
6.5.12 Mean treatment delay 
The delay in starting the treatment once the diagnosis is made is considered as 
treatment delay. The mean treatment delay was 2 days in the present study (95% CI 
2.1-3.6) with a maximum delay of 28 days (Table 6.20). This was because one patient 
couldn`t accept the fact that he was attacked with TB; in denial he changed the doctors 
and only when the symptoms worsened he started the treatment. 
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Table 6.20 Treatment delay 
Type of delay Mean 95%CI Median Min Max 
Treatment delay (after diagnosis 
to initiating treatment) 
2 2.1-3.6 2 0 28 
 
6.5.13 Delay in initiation of treatment on those who are transferred out 
The mean delay in initiation of treatment in patients who were transferred out was 4.5 
days with a maximum delay of 60 days with 95% CI of 1.9-7.1(Table 6.21).  
Table 6.21 Delay in initiation of treatment on those who are transferred out 
Type of delay Mean 95%CI Median min Max 
Among the patients who have been 
referred out, delay in initiating 
treatment 
4.5 1.9-7.1 2 0 60 
 
6.5.14 Mean Centre delay 
The delay in diagnosis after the visit to the first health care provider was centre delay 
(first health centre to final health centre). The mean centre delay was 60.8 days (Table 
6.22) with maximum delay of 358 days (95% CI 42.3-78.8). 
Table6.22 Centre of delay 
Type of delay Mean 95%CI Median min Max 
Centre delay 60.8 42.3-78.8 16 0 
 
 
358 
 
6.5.15 Mean Total delay 
The total delay from the onset of symptoms to initiation of treatment in a patient with 
new sputum positive TB is calculated in the present study. The mean total delay was 
104.8 days (95% CI 84.4-125.2) with a range from 5 to 549 days (Table 6.23). 
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Table 6.23 Total delay 
Type of delay Mean 95%CI Median min Max 
Total delay 104.8 84.4-
125.2 
91 5 
 
 
549 
 
Summary table of different delay: 
The different levels of delays are listed below in Table 6.24. The maximum delay is 
after seeking treatment to diagnosis of TB and the next is the patient delay. 
Table 6.24 Delay 
Type of delay Mean 95%CI Median min Max 
Patient delay in reaching health 
facility for diagnosis 
38.5 25.3-51.6 20 2 540 
Centre delay 60.8 42.3-78.8 16 0 358 
Health system delay in diagnosing 99.3 79.5-
119.1 
90 3 547 
Treatment delay (after diagnosis to 
initiating treatment) 
2 2.1-3.6 2 0 28 
Among the patients who have been 
referred out, delay in initiating 
treatment 
4.5 1.9-7.1 2 0 60 
Total delay 104.8 84.4-
125.2 
91 5 
 
549 
 
6.5.15 Distance from home to DOTS 
The proportion of people who said that the distance to DOTS centre 1.1 km to 3 km 
was 42.1% where as 34.7% patients said the distance to DOTS centre was up to 1 km 
(Figure 6.8). Mean distance is 2.9 km (95% CI 2.2 to 3.6) and median is 2 km`s. 
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Figure 6.8 Distances from Home to DOTS Centre 
 
 
6.5.16 Perception of the patients as they had symptoms of TB 
The proportion of the patients who suspected that the symptoms could be because of 
TB attributes to 22.1% (21). The proportion of patients who heard about TB in their 
life was 35.8% (34). 
6.5.17 Perception of seriousness of the illness by patients: 
Among the patients 50.5% of them feel that it is very serious to oneself, 35.8% feels 
that it is somewhat serious (Figure 6.9). The proportion of who considers TB as very 
serious in the community is 54.7% and 32.6% considers it as somewhat serious to the 
community. 
Figure 6.9 Perception of seriousness of TB according to patient and community 
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6.6 KNOWLEDGE 
6.6.1 Knowledge of the symptoms of TB among the patients: 
Majority of participants with TB know the symptoms. The proportions of the patients 
who know cough more than 2 weeks and weight loss as symptom of TB is 89.5%. 
Among the patients 77.9% know loss of appetite as the symptom of TB. 80%of them 
know evening rise of temperature as symptom of TB. Only 43.2% of them say 
haemoptysis is a symptom of TB (Table 6.26).  Majority of participants without TB 
knew that cough and loss of weight are symptoms of TB. 
6.25 Knowledge of the symptoms of TB among the patients: 
 
 
 
 
 
 
6.6.2 Knowledge of transmission of TB: 
The proportion of people who said that TB is transmitted by cough and sneeze is 
71.6%, 54.7% said that it is transmitted by sharing utensils. Those who said 
transmission was by touch accounts to 29.5% and 26.3% said it was transmitted by 
sitting next to someone with TB. Among the general population, knowledge is very 
high, 98% knew that the transmission is through air (Table 6.26). 
 
Symptoms Participants with TB Participants 
without TB 
N % No & % 
Cough >2 weeks 85 89.5 71 
Hemoptysis 41 43.2 62 
Weight loss 85 89.5 97 
Loss of appetite 74 77.9 66 
Fever at evening/night 76 80 46 
Chest pain 50 52.6 50 
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Table 6.26Knowledge of transmission of TB 
 
 
 
 
 
 
 
6.6.3 Knowledge on prevention and cure of TB: 
The proportion of people who said that TB can be prevented by covering while 
sneezing or coughing was 80%, 74.7% said it could be prevented with good nutrition. 
Among the general population, 99% knew that covering while coughing/sneezing 
prevents transmission of TB. 
Table 6.27 Knowledge on prevention and cure of TB 
 
 
 
 
 
 
96.8% of the participants with TB and 100% of general population m opined that TB 
can be cured. 
 
Mode of transmission  Participants with 
TB  
Participants without 
TB 
N % No & % 
Cough/sneeze 68 71.6 98 
Touch 28 29.5 23 
Sitting next to someone 
with TB 
25 26.3 17 
Sharing utensils 52 54.7 22 
Hereditary 13 13.7 0 
Contagious 18 18.9 77 
Mode of Prevention  Participants with 
TB 
Participants 
without TB 
 N % No & % 
Covering while 
coughing/sneezing 
76 80 99 
Avoid sharing meals 61 64.2 56 
Good ventilation 57 60 54 
Good nutrition 71 74.7 95 
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6.6.4 Knowledge of treatment and duration of treatment 
Among the patients 93.7% said that TB d with regular can be treated with regular 
medicines, 71.6% said that TB can be cured by proper nutrition (Table 6.28). 
The proportion of patients who said duration of the treatment for TB is 6 months was 
77.9% and 14.7% of them are not aware of the duration of treatment. 
Table 6.28 Knowledge of treatment and duration of treatment 
 
6.6.6 Knowledge regarding repeat sputum testing after initiation of sputum 
Only 63.2% of the newly sputum positive TB patients were regarding the sputum 
testing after initiation of treatment, of those who were aware 50% feel that sputum 
needs to be checked only once (Table 6.29). 
Table 6.29 Knowledge regarding repeat sputum testing after initiation of sputum 
 
 
 
Treatment Variable N % 
Regular  medicines 86 93.7 
Proper nutrition 68 71.6 
Duration of treatment < 6 months 6 6.4 
6 months 74 77.9 
7 to 9 months 1 1.1 
Not known 14 14.7 
Regarding sputum 
testing (among patients 
only) 
Variable N % 
Aware that sputum should 
be checked 
Yes 60 63.2 
No of times  Once 30 50 
Twice 19 31.7 
Three times 2 3.3 
Not sure 9 15 
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6.9.4 Knowledge of timing of repeat sputum sample 
Among the 60 patients who were aware of repeat sputum examination 51.7% said that 
it should be repeated after 2 months and 21.7% of them said that they were not sure. 
6.30 Knowledge of timing of repeat sputum testing  
 
 
 
Knowledge on timing of testing sputum (follow up) was not much; only 51.7% knew 
that it should be tested at 2 months. Their knowledge on sputum testing at 6 months is 
very poor (Table 6.30) 
6.7 Knowledge among participants regarding susceptibility to TB 
6.7.1 Knowledge among study participants with TB regarding the susceptible 
individuals for TB 
88.4% of the study participants with TB said that anyone can get TB, 30.5 said that 
people who consume alcohol are highly susceptible to get TB. Among the general 
population, 95% knew that anyone can get TB.  
Table 6.31 Awareness among participants with TB regarding susceptible 
individuals for TB 
 
 
 
 
 
Timing of repeat 
sputum testing 
N % 
1 month 9 15 
2 months 31 51.7 
3 months 5 8.3 
6 months 2 3.3 
Not sure 13 21.7 
Who can get tuberculosis Participants with TB Participants without TB 
 N % No & % 
Any one 84 88.4 95 
People with HIV 10 10.5 2 
People with DM  15 15.8 5 
People with Alcoholism 29 30.5 10 
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6.7.2 Knowledge scores among participants with TB patients and general 
community: 
Mean knowledge score among people with Tuberculosis was 16.2; SD=3.1 (15.6-
16.9). Mean knowledge score among general community was 16.34; SD=2.4 (15.8-
16.2). 
Poor knowledge was given a score of below 17, average knowledge was given a score 
of 17-19 and good knowledge was given a score 20 and above.  
Among the study participants with TB, 35.8% had poor knowledge and 37.9% had 
average knowledge. Only 26.3% of them had good knowledge. 
Among the study population in the general 44% had average knowledge regarding the 
disease and only 22% had good knowledge as compared to rest of the population 
(table 6.32). 
      Table 6.32 Knowledge among TB patients and general community 
  TB patients 
      N                  % 
General 
community 
    N              % 
Poor 17 34 35.8 34 34 
Average 17-19 36 37.9 44 44 
Good >/20 25 26.3 22 22 
 
6.8 Perception of Stigma 
A validated questionnaire with the 11 items on perception of people living with TB 
about how community perceive or feel about Tuberculosis (Community Tuberculosis 
Stigma Perception -11 items) and 12 items on the perception of people living with TB 
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about how Patients (Person) perceive or feel about TB (Patients’ Stigma Perception - 
12 items) was administered to the people with TB and people without TB. 
After the analysis, the stigma in the community was scored. For the community 
perception of stigma among the TB patients the mean score was 1.96 with an SD 0.5 
and in the general population mean score 1.7 and 0.4 as SD. The percentage mean 
score was 65.4 with 16.7 among TB patients; in the general population it was 59.9 and 
the standard deviation was 12.8 (Table 6.33). For the patient perception of stigma 
among the TB patients the mean score was 1.8 with an SD 0.4 and in the general 
population mean score 1.8 and 0.3 as SD. The percentage mean score was 59.24 with 
14.5 among TB patients; in the general population it was 59.8 and the standard 
deviation was 9.7. 
 Table6.33 Stigma in the study population 
 TB patients 
 
    MEAN               SD 
General 
community 
MEAN    SD 
Community perspectives toward 
tuberculosis - Mean score 
 
1.96  
0.5 
1.7 0.4 
Community perspective towards 
tuberculosis-%mean score 
65.4 16.7 59.9 12.8 
Patient perspectives toward tuberculosis – 
Mean score 
1.8 0.4 1.8 0.3 
Patient perspective toward tuberculosis - 
%mean score 
59.24 14.5 59.8 9.7 
 
Stigma was further classified as mild, moderate and severe. A score of less than 1.75 
was considered as mild stigma, 1.75-1.99 was considered as moderate stigma and a 
score of more than or equal to 2 was classified into severe stigma. 
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Among participants with TB, nearly 50% had severe level of stigma (patient 
perspective) and 35.8% had moderate level. In the general community, 57% had 
moderate and 12% had severe level of perceived stigma (patient perspective). 
Table: 6.34 Stigma in patient perspective categorized 
Level of stigma  Score TB patients 
 
N                 % 
General 
community 
N                % 
Mild <1.75 14 14.7 31 31 
Moderate 1.75-1.99 34 35.8 57 57 
Severe >/2 47 49.5 12 12 
 
The level of stigma (community perspective) according to patient was severe in 33.7% 
and moderate in 30.5% where as in the general community, 45% severe and 33% 
moderate (Table 6.35). 
Table: 6.35 stigma in community perspective categorized 
Level of 
stigma 
score  TB patients General 
community 
 
N % N % 
Mild <1.75 34 35 22 22 
Moderate 1.75-1.99 29 30.5 33 33 
Severe >/2 32 33.7 45 45 
 
6.9 Measurement of associations: 
In the present study, the association between knowledge and various factors was 
carried out on all the 195 participants (patients + general community) who were 
interviewed. Odds of exposure to various factors such as age, gender, education, 
occupation, socio economic status (SES), residential status,  h/o TB (past and family), 
drinking and smoking; for knowledge were calculated by univariate analysis and 95% 
confidence interval was estimated. Age, gender did not show any significant 
 62 
 
association with knowledge (Table 6.36). Those with lower education chose to do 
unskilled jobs or stay unemployed and eventually reflect in lower socioeconomic 
strata; and show chance of low knowledge which was not statistically significant.  
6.9.1 Knowledge in study population 
Table 6.36 Knowledge (n=195) in study population 
Variable Categories Knowledge p-value Unadjusted 
OR & 95%CI 
Adjusted 
OR & 
95%CI 
Low (%) High (%) 
Age Upto 35 21(43.8) 27(56.2) 0.137 0.6 
(0.31-1.15) 
0.698 
(0.32-1.52) > 35 years 83(56.5) 64(43.5) 
Sex Female 40(51.3) 38(48.7) 0.663 0.87 
(0.491-1.54) 
0.711 
(0.32-1.58) Male 64(54.7) 53(45.3) 
Education Upto 5 50(60.2) 33(39.8) 0.111 1.627 
(0.916-2.89) 
1.655 
(0.79-3.46) >5
th
 class 54(48.2) 58(51.8) 
Occupation Nil/Unskilled 43(58.9) 30(41.1) 0.239 1.433 
(0.798-2.576) 
1.219 
(0.61-2.43) Others 61(50.0) 61(50.0) 
SES Low 66(53.2) 58(46.8) 1.000 1.012 
(0.564-1.816) 
1.370 
(0.69-2.72) Middle 38(53.5) 33(46.5) 
Residence Urban 2(40.0) 3(30.0) 0.666 0.575 
(0.094-3.52) 
0.49 
(0.07-3.33) Rural 102(53.7) 88(46.3) 
Smoking Ever  35(51.5) 33(48.5) 0.764 0.89 
(0.494-1.60) 
0.564 
(0.22-1.47) Never  69(54.3) 58(45.7) 
Alcohol Ever  29(52.7) 26(47.3) 0.967 1.000 
(0.517-1.80) 
1.07 
(0.43-2.69) Never  75(53.6) 65(46.4) 
TB Present 5(71.4) 2(28.6) 0.452 2.247 
(0.425-11.8) 
0.741 
(0.43-2.72) Absent 99(52.7) 89(47.3) 
Family 
history of TB 
Present 10(52.6) 9(47.4) 0.949 0.969 
(0.376-2.501) 
0.74 
(0.25-2.20) Absent 94(53.4) 82(46.6) 
 
6.9.2 Perception of stigma: 
Stigma is one of the hindrances for the control of tuberculosis. On univariate analysis 
of community perception of stigma among 195 study participants (patients + general) 
with various factors such as age, sex, marital status, education and other factors as 
shown in the table 6.37. It was found that perception of stigma was more among men. 
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In the same way ever smokers and people with TB perceive more stigma as compared 
to others.  
Table 6.37 Community perception of stigma related to TB (N=195) 
Variable Categories Stigma p-value Unadjusted OR & 
95%CI 
High Low 
Age Upto 35 12(25.0) 36(75.0) 0.469 1.410 
(0.673-2.954) 
> 35 years 47(32.0) 100(68.0) 
Sex Female 15(19.2) 63(80.8) 0.007* 2.532 
(1.29-4.98) 
Male 44(37.6) 73(62.4) 
Education Upto 5 29(34.9) 54(65.1) 0.270 0.681 
(0.37-1.26) 
>5
th
 class 30(26.8) 82(73.2) 
Occupation Nil/Unskilled 22(30.1) 51(69.9) 1.000 1.009 
(0.537-1.898) 
Others 37(30.3) 85(69.7) 
SES Low 45(36.3) 79(63.7 0.016* 2.319 
(1.164-4.623) 
Middle 14(19.7) 57(80.3) 
Residence Urban 1(20.0) 4(80.0) 1.000 1.758 
(0.192-16.06) 
Rural 58(30.5) 132(69.5) 
Smoking Ever  32(47.1) 36(36) <0.001* 0.304 
(0.160-0.575) 
Never  27(21.3) 100(78.7) 
Alcohol Ever  24(43.6) 31(56.4) 0.015 0.431 
(0.223-0.830) 
Never  35(25.0) 105(75.0) 
Marital status Unmarried 11(52.4)  10(47.6)  0.025  2.88  
(1.152-7.236) 
Ever married 48(27.6)  126(72.4)  
Family history 
of TB 
Present 5(26.3) 14(73.7) 0.798 1.239 
(0.425-3.614) 
Absent 54(30.7) 122(69.3) 
Knowledge Low/Average 25(24) 79(76.0) 0.060 1.885 
(1.015-3.499) 
High 34(37.4) 57(62.6) 
Presence of 
TB 
Present 12(12.0)  88(88.0)  <0.001 * 0.139  
(0.067-0.288)  
Absent 47(49.5)  48(50.0)  
* Statistically significant 
 
6.9.3 Multivariate analysis for perception of stigma: 
A multivariate analysis is performed on the variables which showed statistically 
significant in univariate analysis. The variable includes sex (p value 0.007, OR=2.532 
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& 95% CI1.29-4.98); SES (p value 0.016, OR=2.319 & 95% CI 1.164-4.623); 
smoking (p value <0.001, OR=0.304 & 95% CI 0.160-0.575); alcohol (p value 0.015, 
OR=.431 & 95% CI 0223-0.830); marital status ( p value 0.025, OR 2.88 & 95% CI 
1.152-7.236); presence of TB (p value <0.001, OR 0.139 95% CI 0.067-0.288). On 
adjusting for the above mentioned variables as shown in the table 6.38, only people 
with TB were found to have more perception of stigma, which was statistically 
significant. 
Table:6.38 Logistic regression model for factors associated with community 
perception 
Variables  Categories  Perception of stigma P value OR 
 
95% CI 
AOR 
 
95% CI High  Low  
Sex  Female   15(19.2) 63(80.8) 0.406 2.532 
(1.29-4.98) 
0.663 
(0.252-1.745) 
Male   44(37.6) 73(62.4) 
SES Low 45(36.3) 79(63.7) 0.104 2.319 
(1.164-4.623) 
0.531 
(0.247-1.140) Middle  14(19.7) 57(80.3) 
Smoking Ever  32(47.1) 36(36) 0.152 0.304 
(0.160-0.575) 
2.293 
(0.738-7.125) 
Never  27(21.3) 100(78.7) 
Alcohol Ever  24(43.6) 31(56.4) 0.348 0.431 
(0.223-0.830) 
0.590 
(0.196-1.777) 
Never  35(25.0) 105(75.0) 
Marital 
status 
Unmarried 11(52.4)  10(47.6)  0.150 2.88  
(1.152-7.236) 
2.201 
(0.75-6.45) 
Ever married 48(27.6)  126(72.4)  
Patients with 
TB/ general 
community 
Patient with TB 12(12.0)  88(88.0)  <0.001* 0.139 
(0.067-0.288)  
0.199 
(0.088-0.451) 
General 
community 
47(49.5)  48(50.0)  
* Statistically significant 
 
6.9.4 Perception of stigma in study participants with TB: 
The perception of stigma among 195 participants is studied with the help of 12 point 
stigma scale – a validated tool from van Rie et al study. In the univariate analysis as 
well as after adjusting for odds with various factors as shown in the table people with 
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good knowledge has more perception of stigma which is statistically significant 
(Table 6.39).  It could probably be explained as they know the symptoms of TB they 
have many associated fears with it. 
Table:6.39 Perception of stigma in study participants with TB 
Variable Categories Stigma p-value Unadjusted OR 
& 95%CI High Low 
Age Upto 35 14(29.2) 34(70.8) 0.125 
 
1.821 
(0.902-3.67) > 35 years 63(42.9) 84(57.1) 
Sex Female 29(37.2) 49(62.8) 0.655 1.715 
(0.652-2.118) Male 48(41.0) 69(59.0) 
Education Upto 5 38(45.8) 45(54.2) 0.139 0.633 
(0.354-1.31) >5
th
 class 39(34.8) 73(65.2) 
Occupation Nil/Unskilled 31(42.5) 42(57.5) 0.547 0.820 
(0.454-1.48) Others 46(37.7) 76(62.3) 
SES Low 54(43.5) 70(56.5) 0.132 1.610 
(0.874-2.965) Middle 23(32.4) 48(67.6) 
Residence Urban 1(20.0) 4(80.0) 0.650 2.667 
(0.292-24.3) Rural 76(40.0) 114(60.0) 
Smoking Ever 28(41.2) 40(38.8) 0.760 0.897 
(0.492-1.636) Never  49(38.6) 78(61.4) 
Alcohol Ever  23(41.8) 32(58.2) 0.745 0.874 
(0.463-1.64) Never  54(38.6) 86(61.4) 
Marital status Unmarried 9(42.9)  12(57.1)  0.815  1.169  
(0.468-2.923)  Married 68(39.1)  106(60.9)  
Family 
history of TB 
Present 6(31.6) 13(68.4) 0.622 1.465 
(0.532-4.035) Absent 71(40.3) 105(59.7) 
Knowledge Low/Average 31(29.8) 73(70.2) 0.003* 2.40 
(1.33-4.33) High 46(50.5) 45(49.5) 
TB Present 3(42.9) 4(57.1) 1.000 0.865 
(0.19-3.78) Absent 74(39.4) 114(60.6) 
* Statistically significant 
6.9.5 Factors affecting delay in study participants with TB 
Delay with a cut off taken as 30 days is categorised to delay of < 30 days and delay of 
> 30 days. To measure the association with various factors as shown in the table both 
univariate and multivariate analysis was performed. The determinants of delay include 
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socio-demographic variables like age, gender, education, occupation, type of house, 
type of family and economic status of the family.  
Table: 6.40 Factors affecting delay in diagnosis and initiation of treatment in TB 
patients 
* Statistically significant 
 
Variable Categories Delay p-value Unadjusted 
OR & 
95%CI 
> 30 
days(%) 
<30 
days(%) 
Age Upto 35 14(56) 11(44) 0.257 1.714 
(0.672-4.376) > 35 years 48(68.6) 22(31.4) 
Sex Female 14(58.3) 10(41.7) 0.410 1.49 
(0.576-3.86) Male 48(57.6) 23(32.4) 
Education Upto 5 31(66.0) 16(34.0) 1.000 0.941 
(0.404-2.19) >5
th
 class 31(64.6) 17(35.4) 
Occupation Nil/Unskilled 32(74.4) 11(25.6) 0.088 0.469 
(1.104-6.987) Others 30(57.7) 22(42.3) 
SES Low 49(72.1) 19(27.9) 0.034* 2.77 
(1.922-42.56) Middle 13(48.1) 14(51.9) 
Residence Urban 3(60.0) 2(40.0) 0.800 1.269 
(0.201-7.99) Rural 59(65.6) 31(34.4) 
Smoking Ever  36(69.2) 16(30.8) 0.372 0.680 
(0.291-1.59) Never  26(60.5) 17(39.5) 
Alcohol Ever  31(70.5) 13(29.5) 0.324 0.650 
(0.276-1.532) Never  31(60.8) 20(39.2) 
Family history of TB Present 9(56.2) 7(43.8) 0.409 1.585 
(0.531-4.732) Absent 53(67.1) 26(32.9) 
Knowledge Low/Average 38(71.7) 15(28.3) 0.193 0.526 
(0.224-1.237) High 24(57.1) 18(42.9) 
Stigma- community Low/Average 28(58.3) 20(41.7) 0.197 1.868 
(0.791-4.410) High 34(72.3) 13(27.7) 
Stigma – patient Low/Average 39(61.9) 24(38.1) 0.371 1.573 
0.625-3.959 High 23(71.9) 9(28.1) 
Distance to health 
centre 
Upto 1 Km 22(66.7) 11(33.3) 1.000 0.909 
(0.373-2.217) 
>1 Km 40(64.5) 22(35.5) 
Debt due to medical 
expenses 
Present 32(82.1) 7(17.9) 0.005* 0.252 
(0.095-0.667) Absent 30(53.6) 26(43.4) 
No. health facilities 
visited 
>2 centres 40(83.3) 8(16.7) <0.001* 5.682 
(2.195-14.7) Upto 2 centres 22(46.8) 25(53.2) 
Health seeking 
behavior 
Self/chemist 21(58.3) 15(41.7) 0.278 0.615 
(0.259-1.458) Health centre 41(69.5) 18(30.5) 
Health facility Private 43(70.5) 18(29.5) 0.181 
 
0.530 
(0.222-1.269) TB centre 19(55.9) 15(44.1) 
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From the above table, patients from lower socio economic status had experienced 
more delay as compared to middle socio economic status. It was statistically 
significant with a p-value of 0.034 and odds ratio of 1.5 which shows those of low 
S.E.S had 2.77 times higher chance of delay more than 30days for treatment of TB. 
Patients who had taken more debts due medical expenses had also experienced more 
delay with a p-value of 0.005 and odds ratio of 1.5. This was statistically significant 
and shows that those who had debts due to medical expenses tend to have 2.77 times 
higher chance of being delayed in acquiring treatment with in adequate time. 
6.9.6 Multivariate analysis for delay  
Table:6.41 Multivariate regression model for delay  
* Statistically significant 
 
Among the 95 patients in the study those who had to visit more than 2 health centres  
found to have 5.77 times more chances of delay to the treatment as compared to other 
who contacted at least 2 health centres for the treatment, which was statistically 
significant. 
Variable   Delay  P value OR  
95% CI 
AOR 
95% CI  
>30 days <30 days 
Debt due to 
medical 
expenses 
Present 32(82.1) 7(17.9) 0.433 0.252 
(0.095-0.667) 
0.628 
(0.196-2.010)  Absent 30(53.6) 26(43.4) 
No. health 
facilities 
visited 
>2 centres 40(83.3) 8(16.7) 0.004* 5.682 
(2.195-14.7) 
5.342 
(1.699-16.802)  Upto 2 
centres 
22(46.8) 25(53.2) 
Socio 
economic 
status  
Low  49(72.1) 19(27.9) 0.278  
2.77 
(1.922-42.56) 
3.370 
(1.162-9.778)  Middle  13(48.1) 14(51.9) 
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On adjusting for various other factors as shown in the table, people with low S.E.S, 
who had debts due to medical expenses and those who had to visit more than 2 health 
centres were found to statistically significant. 
This could be explained as patients from lower economic status due to poverty had 
often visited local doctors, waited with the anticipation that symptoms would get 
better with the available treatment. But this eventually prolonged the duration and 
severity of symptoms and led to more debts as they lost their daily wages due to 
sickness. The present study gives a significant result that poverty is still the main 
reason for this vicious circle of the disease 
 
 
 
  
 69 
 
7. Discussion 
Tuberculosis is a preventable as well as curable disease. Since the disease is 
contagious; it stands as a global health problem. The disease is highly wide 
spread(45).Under W.H.O initiative with DOTS, to increase success of TB treatment it 
emphasizes on passive case finding. Since the passive case finding depends on their 
willful appearance before the health facility which indirectly reflects on their health 
seeking behaviour. In a scenario like this there are high chances of delay in seeking 
health care with onset of symptoms(14). 
The delay in approaching a health care provider with initiation of symptoms will 
increase the bacillary load and pose a threat to increased transmission of the disease. 
Each of the infected patients with smear positivity are highly infective and has the 
potential to infect 10 other people in their life time(8).Prolonged delay can lead to 
increased infectivity in the community and severe morbidity(46). 
Hence the present study aimed at identifying the causes of delay. This is important in 
case detection and further elimination of the disease. If case finding is improved, it 
may save lives 10 times as DOTS alone(16). 
The present study is a cross sectional study done to analyze the factors affecting the 
delay in diagnosis and initiation of treatment in newly diagnosed sputum positive 
pulmonary tuberculosis who registered under CHAD-TU during the period of 
November 2014 to May 2015.One of the major risk factor for delay, as perceived from 
various studies is stigma(35).The level stigma in the community as well as in the 
patient group is analyzed. 
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In the present study among the 95 patients those who had to visit more than 2 health 
centers were found to have 5.77 times more chances of delay to the treatment as 
compared to other who contacted at least 2 health centers for the treatment, which was 
statistically significant. Low SES and debts due to medical expenses were found to 
have significant association with delay in diagnosis of treatment (univariate analysis).  
Several studies show that repeated visits to health centers or same health centre at the 
same level is the main problem for delay in diagnosis or initiation of treatment(9). 
This is a vicious circle that causing delay, in Burkina Faso since specialized services 
were poor many of the patients had repeated consultations at the same level of health 
care(47). In Ghana the health personnel were under trained; hence proved to be reason 
for delay and was correlated with failure to do sputum microscopy (r=0.99) (48). In a 
study done in Malaysia only 11% of the patients were diagnosed in the initial and 45% 
of them in the third consultation(49). In another study done in Malaysia sputum 
microscopy, chest X-ray were underutilized and indicating low awareness of private 
practitioners(50). A similar report was found in New Zealand study thought the 
patient had classical symptoms at least no sputum microscopy was not performed(51). 
 
The mean delay in the present study in reaching the health facility is 38.5 days and 
median is 20 days which is similar as compared to studies done in similar settings in 
Pakistan and United States. The total delay till diagnosis (median 90 days) is also 
similar as compared to studies in Malaysia, Pakistan and the US. 
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TABLE:6.42 MEDIAN DIAGNOSTIC DELAY IN COMPARISION WITH OTHER 
STUDIES 
Country  Year  First author  DDPAT DDHC Tot DD Reference 
PRESENT STUDY 20 16 90  
Tanzania  2000  Wandwalo 15 120 136 (36) 
United 
kingdom 
2003 Lewis  63 36 126 (52) 
Burkina Faso 2006 Ouedraogo * * 120 (51) 
Ghana 1998 Lawn 28 56 120 (53) 
Pakistan 2006 WHO 9 87 91 (54) 
Malaysia 1994 Hooi 15 35 90 (49) 
United States 2005 Golub 32 26 89 (55) 
DDPAT-Patient delay (time from first onset of symptoms to first visit to health 
centre/provider 
DD HCP-health care provider delay (Diagnostic Delay by the Health Care Providers): 
Time taken from first visit to a HC till the making of a proper diagnosis 
DD Total (Total Diagnostic Delay): Time from onset of symptoms till proper 
diagnosis 
*unavailable 
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7.1 Socio demographic profile characteristics:  
 Majority of the patients interviewed were men, predominantly (90%) from rural area. 
Inclusion criteria being those of more than 18 years of age, 25.3% of them belong to 
age group of 18 to 35 years 48.4% of them falls to 35 to 60 years age group with rest 
of them belonging to above 60 years of age. 
Higher proportion of the subjects have nil or education up to primary school only. Of 
the study population majority were unemployed; of which 29.5% are unskilled daily 
wage labourers; 94.7% hail from rural background.  
In the general population 44% of them were above 60 years; 54% female and entire 
study population was from rural background. 
7.2 Personal characteristics: 
Smoking is predominantly abused by 54.9% of them (current and past smokers); most 
of them are current smokers. They were smokers for more than 30 years and been 
smoking at least 11 to 10 cigarettes/beedis per day. Most of them smoked beedis as 
they were of low price. 
A proportion of 46.3% of them were alcohol abusers, among those who abused 
alcohol 20.5% of them consumed more than 2000ml of alcohol per day. Due to heavy 
consumption of alcohol, there were patients who found to have defaulted in the later 
months. There were 2 deaths which later came to notice with a similar issue. 
Patients had multiple symptoms as they showed up in the health facilities. Cough 
(93.7%), fever (85.3%), loss of weight (84.2%) and loss of appetite (83.2%), 
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haemoptysis (22.1) and chest pain (18.9%) were the symptoms as mentioned by them. 
But only 40% of them sought treatment as they had cough and 28.4% for fever. In a 
study done in central India 94% of the patients complained of cough more than 2 
weeks(56). 
A large proportion of them sought health centers with the onset of symptoms of which 
43.2% approached private hospitals and rest to various government health facilities 
such as PHC (12.6%) with the onset of symptoms. The similar finding was found in a 
study done in central India where private providers were visited more often than 
government health centers (63.5% vs. 31.2%; P < 0.001) (17). In a study done in ten 
districts of Tigray region, Ethiopia; showed that 54% of the patients received help 
from formal health providers(57).  
 
The time taken for the patient to approach health facility with the onset of symptoms 
is taken as patient delay. The mean patient delay was 38.5 days.  Most of them 
thought it was not necessary (50%) to approach health centre early and tried self- 
medication (29.4%). Even in a study done in Bahir Dar city, Ethiopia they found 
multiple reasons attributing to delay (mean delay 21 days) such as (90%) thought that 
symptoms would disappear and in others it was due to financial problem (28.4%)(58). 
Among the patients group one person (1.1%) tried and waited using `Sidda` medicine 
as he himself was Sidda provider. In a study done in Ethiopia  1.2% approached 
traditional healers(59). This shows there is a group which still waits on traditional 
medicine for the cure of TB. Association between patients delay and non-formal 
health providers was statistically significant and it increased health system delay in an 
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Ethiopian study (25) One of the patient in the study group delayed as he was 
misdiagnosed with typhoid in the initial centre, later was told to have 
dengue/chickungunya for his consistent symptom of fever and only was diagnosed 
when he finally reached a higher centre (GVMCH). In this patient the delay was 
almost 3 years duration. In a study done in Gambia TB is often misdiagnosed as 
malaria of viral infection(60). 
Health care facility where patient first sought treatment for TB was private hospital 
(64.2%).The initial diagnosis of TB was made by GVMC (Government Medical 
College-Vellore) for a proportion of 35.8% and 32.6% of the patients were diagnosed 
in CHAD. 
Out of the interviewed 58.9% of them did not have any debts due to medical expenses, 
but 21.1% of them had debts in the range of Rs.10001 to 50000. Money spent on 
approaching health providers for treatment with both direct and indirect costs was 
counted. Total cost before diagnosis spent by 38.9% of them was up to Rs.500; only 2 
of them spent money of more than Rs.50, 000 before diagnosis. In the present study 
patients who had taken more debts due medical expenses had also experienced more 
delay with a p-value of 0.005 and odds ratio of 1.5. This was statistically significant 
and shows that those who had debts due to medical expenses tend to have 2.77 times 
higher chance of being delayed in acquiring treatment with in adequate time. 
Accessibility was the reason in 62.1% of them; while 31% of them chose as they had 
more confidence in that particular provider. 
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Sputum examination was done in 98.9%, blood tests were done in 96.8% of them 
where as 88.4% of them also had chest x-rays taken. This shows that almost all 
facilities they approached had the required laboratory tests available to diagnose the 
disease adequately. But the only gap was that there was delay in approaching the right 
facility. In the present study the mean diagnostic delay or treatment delay was 2 days. 
The proportion of 47.4% patient`s thought it was not necessary to go to these centers 
where as 27.4% of them couldn’t go as they have no money. But 9 of them have 
immediately approached their regular health provider and waited to be cured of the 
sickness until they were diagnosed of TB. The proportion of patients who experienced 
a delay of 91-180 days was 26.3%. 
A delay of 31-90 days in diagnosis of the disease was experienced by 24.2% of them. 
Among those who had delayed; a proportion of 67.4% responded that they consider it 
as delay. The proportion of people who were 1.1 km to 3 km away from DOTS centre 
(facility) were 42.1% ; where as those that were 1 km away were 34.7%.Mean 
distance from home to DOTS center is 2.9 km (95% CI 2.2 to 3.6) and median is 2 
km. 
The time taken from the first onset of symptoms to till it was diagnosed is health 
system delay, and the mean health system delay was 99.3 days. 
In the present study, age, gender did not show any significant association with 
knowledge. Those with lower education chose to do unskilled jobs or stay 
unemployed and eventually reflect in lower socioeconomic strata; and show chance of 
low knowledge which was not statistically significant. 
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Stigma is one of the hindrances for the control of tuberculosis. On univariate analysis 
of community perception of stigma among 195 study participants (patients + general) 
with various factors such as age, sex, marital status, education and other factors as 
shown in the table below. It was found that perception of stigma was more among 
men. In the same way ever smokers and people with TB perceive more stigma as 
compared to others. But after adjusting for various factors as shown in the table only 
people with TB were found to have more perception of stigma, which was statistically 
significant. It could probably be explained as they know the symptoms of TB they 
have many associated fears with it.  
Patients from lower economic status due to poverty had often visited local doctors, 
waited with the anticipation that symptoms would get better with the available 
treatment. But this eventually prolonged the duration and severity of symptoms and 
led to more debts as they lost their daily wages due to sickness. The present study 
gives a significant result that poverty is still the main reason for this vicious circle of 
the disease. 
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7. Limitations 
 
1. Recall bias could be a possibility; though care was taken to visit patients within 2 
weeks of recruitment. 
2. Most of the patients were very sick and tired of the illness, in few of them their 
responses were influenced by the care giver as they couldn`t recollect. 
3. In the general population people in few villages were completely unaware of the 
disease and not seen any patient in their village, they all answered as no stigma. Hence 
perception of stigma and knowledge of the disease are directly related.  
4. Due to the nature of the cross sectional study design underreporting or over 
reporting of patient delay is unavoidable. 
5. This hospital-based study cannot provide information on individuals who were 
never treated in hospital and who may die untreated in the community. 
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9. Conclusions 
 
The present study aimed at identifying the factors affecting delay in diagnosis and 
delay in initiation of treatment in a newly diagnosed sputum positive patient. 
We included 95 patients with TB and 100 from general population to know stigma in 
community. The mean total delay, patient delay, health system delay, centre delay and 
treatment delay were 104.8, 38.5, 99.3, 60.8 and 2 days respectively. The median    
total delay, patient delay, health system delay, centre delay and treatment delay were 
91, 20, 90,16,2 days respectively.  
This study shows that health care providers do not suspect TB in first contact, and 
investigate for TB and miss on the symptoms. Poor knowledge on TB and stigma 
related to TB also contribute to the delay, awareness creation to the general population 
regarding the treatability and complete cure if diagnosed and treated early is important 
to prevent delay in diagnosis. 
People with TB were found to have more perception of stigma. People with good 
knowledge had more perception of stigma in the community. Other factors that 
independently associated with delay were low SES and number of health centers 
visited.  
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10. Recommendations 
 
The main reason for delay in diagnosis which is identified through the present study is 
number of health facilities consulted before the diagnosis. This shows that the health 
care providers do not suspect TB at the first visit and treat them without investigating 
for TB. Hence, patients visit multiple providers and loose time before diagnosis. As 
per RNTCP, sputum testing is the main strategy for diagnosis. However, this study 
showed that most people had X-ray before diagnosis. Due to inappropriate treatment 
either due to lack of facilities or expertise causes doctor shopping. Hence, regular 
Continued Medical Education programs may improve health personnel’s’ ability to 
diagnose TB earlier. 
Poor knowledge on TB and stigma related to TB also contribute to the delay. Hence, 
awareness creation to the general population regarding the treatability and complete 
cure if diagnosed and treated early is important to prevent delay in diagnosis. 
People from low socio economic strata are at risk of developing TB and this study 
reveals that SES is a significant factor for delay in diagnosis. People from low socio 
economic status are forced to attend local health providers for treatment due to 
financial problems and would eventually delay diagnosis. Hence, along with creating 
awareness, screening programs for active case finding may be arranged at the 
community level.  
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Finally, health workers should be made aware of the symptoms and also the adverse 
effects if left untreated, so that they will be able to encourage the patients to choose 
right health facility. 
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12. Annexures
Annexure 1 
 
Patient information sheet  
(Applicable for the participants >=18 years of age) 
 The following information is provided to inform you about this research project and 
your participation in it. Please read this form carefully and please feel free to ask any 
questions you may have about the study or the information given below. You will be 
given an opportunity to ask questions, and your questions will be answered. Also, you 
will be given a copy of this information sheet. 
Your participation in this research study is voluntary. You are also free to withdraw 
from this study at any time after it starts. 
Purpose of the study:  
Tuberculosis s is a curable disease but it spreads rapidly. If diagnosed and treated on 
time the chain of transmission can be stopped. This study is to find out the various 
difficulties involved in seeking medical help in time and receiving treatment on time.  
Methods to be followed 
We will ask you questions to know when the actual disease process started in you and 
when you first sought medical help. These questions help to identify various issues 
involved in delay in seeking medical help. 
Approximate duration of study 
Five months (December 2014 to April 2015) 
Expected cost 
We will not incur any cost due to your participation in the study 
Descriptions of the discomforts, inconveniences, and/or risk factors that can be 
reasonably expected as a result of participation in the study: 
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The questions that we ask you may not cause any discomfort to you as these are 
focussed only to understand the issues involved in delay in finding out the problem 
and getting treated for it. To avoid any inconvenience, I will meet in the place of your 
convenience either at DOTS clinic or your home. 
Unforeseeable risks 
There are no such risks involved as adequate measures are taken to meet you on your 
convenient time and convenient place. 
Compensation in view of study related injury 
We do not expect any injury related to this and hence will not be compensating you 
monetarily 
Anticipated benefits from this study: 
The main purpose of the study is to find various issues involved in delay in the 
diagnosis of TB, in spite of government`s active interventions in reaching out to help. 
As we interview you we will be able to identify required information. This study and 
the interview we conduct is as much as a mutual exchange of knowledge where your 
awareness about TB will increase.By participation in the study, participants’ 
awareness and knowledge about disease transmission and treatment will improve. 
Compliance to treatment will also improve and efforts to reduce their perception on 
stigma can be done. Any associated illness or noncompliance of the participant can be 
taken care of by the team at base hospital with the consent of the participant where 
free treatment can be given. 
After the focus group discussions, the community’s awareness can be identified and 
knowledge can be imparted 
 
Compensation for participation: 
We will not give money to answer questions or be a part of this study. 
Circumstances under which the principal investigator may withdraw you from the 
study participation: 
If you wish not to answer questions or do not want us to contact or meet regarding this 
particular study we can withdraw you from this study. If you withdraw, this will not 
stop us from providing medical care for you or your family. 
What happens if you choose to withdraw from the study participation? 
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The information you give us will not be used by us. All collected information will be 
destroyed. 
Confidentiality: 
All efforts, within reason, will be made to keep your personal information in the 
research record confidential. It will not be shared with anyone else. 
Privacy  
Your identity will not be revealed to anyone else; however summary data of the study 
may be shared with Institutional Review Board of Christian medical college and used 
for publication for scientific purpose. 
Contact information: 
If you have any questions about this research study or possibly, please feel free to 
contact: 
Dr.Harika 09159152270      or     Dr.Manjunath o9894262107   or Dr.Jasmine 
9442382466 
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Annexure 2 
 
Consent form 
Study title: To study barriers in early diagnosis and initiation of treatment in people 
with tuberculosis in Southern India. 
Date: 
Study number: 
Name of the study participant: 
Father/mother/husband/partner`s name: 
Age: 
Village: 
 I have read information sheet / i have been informed by the investigator that 
this study is carried out to find out the barriers in delay of early diagnosis and 
thereafter initiation of treatment in people affected with the rural 
tuberculosis. I have understood that the result of the study is to increase the 
awareness among the community. Also to identify the reasons in delay of 
treatment, this is very essential to reduce the transmission of disease to 
achieve a healthy community. 
 
 I understand that my participation in this study is purely voluntary. My 
unwillingness to participate or decision to withdraw will not affect my (family) 
current or future care with any of the programme the investigators institution. 
 
 I understand that my privacy will be maintained and all information given by 
me will be kept confidential and be used for the purpose of the study only. 
However summary results for this study may be shared with for publication 
purposes. 
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 I understand that the investigator and the other researchers will not need my 
permission to look at my study information both in the current study and any 
further research that may be conducted in relation to it. I agree to this access. 
However, i understand that my identity will not be revealed in any 
investigation released to third party investigator or if this study is published. 
 I confirm that i have read (or have read to me in my own language )and 
understood the information sheet for the above study and have had the 
opportunity to ask questions. 
 I agree the investigators contacting me over the phone and meeting me 
personally to know the details related to my illness 
 
Signature / thumb impression of the participant: ---------------------------------------- 
 
 
Signature of the witnesses:-1. ---------------------------------2. ---------------------------- 
 
 
Signature of the investigator: ----------------------------------------------------------------- 
  
If you have any questions about this research study, please contact 
Dr.Harika: o9159152270 
My advisors: 
Dr.Manjunath:09894262107 
Dr.Jasmine:09442382466 
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Annexure 4 
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Annexure 5 
Questionnaire 
General Questionnaire: 
1. Date of interview:     2. Study number: 
3. Village name:      4. T.B registers no. 
5. Name of the respondent 
6. Age       7. Sex: 1. Male 2. Female 
8. Number of household members   9. Number of rooms in the house 
10. Education of the respondent:    11. Education of spouse/father: 
12. Occupationof the respondent prior to illness:  
13. Daily wage/salary prior to illness: 
14. Occupation of the respondent currently: 
15. Daily wage/salary currently: 
16. Occupation (spouse/father): 
17. Family income-pm (prior to illness):   
18. Family income (current)-pm: 
19. Type of house:   1. Hut  2. Thatched 3. Tiled 4. Terraced  
20. Total debt due to medical expense 
21. Residence:   1. Rural 2. Urban 3. Urban slum  4. Homeless 
22. Marital status: 1. Single 2. Married 3. Divorced/separated 4. Widowed 
23. History of smoking: 1. Never 2. Past smoking 3. Current smoking 
24. If 2 or 3 to Q No 23, number cigarettes smoked/day: 
25. Duration of smoking: years-------, months---------- 
26. History of alcohol use: 1. Never 2. Past user  3. Current user 
27. If 2 or 3 to Q No 26, How frequently ……………..  
28. If 2 or 3 to Q No 26, How much per week …….. 
29. Previous history of treatment for TB: 1. No  2. Yes (give details)  
30. Family history of TB:   1. No  2. Yes (Give details) 
 
31. Other chronic illness: 1. none  2. HIV  2. Diabetes 4. COPD 5. 
Bronchial asthma  6. Other (give details) 
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Treatment seeking behavior: 
32. Did you have any of the following symptoms? If yes, write the date of onset 
Code No Symptom Date of onset Duration in days 
1 Cough   
2 Fever   
3 Loss of weight   
4 Loss of appetite   
5 Haemoptysis   
6 Chest pain   
7 Others (specify)  
 
 
 
  
 
33. Which of the above symptom made you seek health care?  
34. Health seekingafter onset of symptoms, but before initial diagnosis and cost of 
consultation: 
Place code 
(in the order 
of sequence) 
Date  Outcome of 
treatment 
Reasons for 
choosing 
Total 
medical 
expenditure 
     
     
     
     
     
     
Code: 
Place of treatment Outcome Reasons 
Code 
No 
Health care provider                    Code 
No 
Outcome Cod
e No 
Reasons 
0 None 0 NA 0 NA 
1 Self-medication 1 No improvement 1 Accessible 
2 Traditional medicine 2 Slight improvement 2 Confidence in getting cured 
3 Pharmacist/chemist 
shop 
3 Worsened 3 Services available any time 
4 PHC 4 Cured, but recurred 4 Referred by private health 
service 
5 Private Doctor 5  5 Free services 
6 GH/CHC   6 Recommended by someone 
7 GVMC   7 Other 
8 CHAD     
9 CMCH     
10 Other     
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35. Reasons for non-consultation of health facility (PHC/GH/CHC/GVMC/CHAD/CMC) 
with the onset of symptoms 
1) Thought ‘as not necessary’   2) Too far 
3)  Too busy health facility/long waiting time 4) Bad experience 
5) No money     6) others (specify) 
36. How long did it take from the time you first feel sick and the time you went to health 
facility? 
37. Do you consider this time as a delay? 1. No  2. Yes 
38. If yes to Q No 37, according to you, what are the causes of delay in your health seeking 
behavior? 
1 Fear of what would be found on diagnosis 5 Unsatisfying staff attitude 
2 Hopped their symptoms would go away on 
their own 
6 Poor quality of health 
services 
3 Fear of social isolation 7 Others (specify) 
4 Economic constraints   
 
39. In the centre where you have been diagnosed, what did they do? (multiple options can 
be ticked) 
1) Gave medicines and review   
2) Sputum testing 
3) Blood testing 
4) X-ray 
5) Other (specify) 
40. Date of testing sputum:    41. Date of diagnosis: 
42. Date of initiation of treatment: 
43. If you have been transferred from some other place to this centre, after how many 
days you have been started on regular treatment?  
44. Distance from your house to the nearest health facility?  
45. Some people do not seek health care when they have the same condition as you have. 
What do you think, the causes would be? 
1) Think it is unnecessary    2)  Too far                                              
3)  Too busy health facility/long waiting time 4) Bad experience                        
5) No money      6) Others (specify) 
 
46. How many days you could not go to work due to your illness (from the time of onset 
of symptom till starting treatment) 
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Knowledge questionnaire on T.B 
 
47. When you suffered from cough or fever or decreased weight and loss of appetite  for 
more than 2 weeks have   you ever thought that you might be suffering from T.B? 
1) No     2) Yes 
48. Before you were diagnosed with TB, have you ever heard about TB? 
1) No 2) Yes 
49 .In your opinion, how serious is tuberculosis?[Read the options and mark one answer 
only] 
1) Very serious 
2) Somewhat serious 
3) Not that serious 
4) Not sure 
50..How serious do you consider the issue of T.B.in your community? [Read the options 
and mark one answer only] 
1) Very serious 
2) Somewhat serious 
3) Not that serious 
4) Not sure 
51. What are the signs and symptoms of tuberculosis? 
1 Cough 7 Evening or night fever 
2 Cough lasting more than 2 weeks 8 Chest pain                  
3 Cough with blood 9 Short of breath 
4 Cough with phlegm 10 Constant fatigue 
5 Loss of weight 11 Loss of appetite 
6 Fever 12 Not sure 
 
52. In which ways, can someone gettuberculosis? (Unprompted, multiple options possible) 
1) By a hand shake                                                        
2) Through air,when somebody with T.B coughs /sneezes 
3) Sharing meals, using same plate/cups 
4) Touching something a person with TB has touched 
5) Sitting next to someone with TB 
6) Hereditary 
7) Contagious disease 
8) Others (specify) 
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53. How can a person prevent from getting this disease? (Unprompted, multiple options 
possible)  
1) Avoiding hand shakes 
2) Covering your mouth or nose while coughing 
3) Avoid sharing meals 
4) Washing your hands after touching something in public places 
5) Opening the windows,having good ventilation 
6) Having good nutrition 
7) Praying 
8) Others 
9) Do not know 
 
54. In your opinion who can get tuberculosis? (Unprompted, multiple options possible)  
1)  Anyone     2)Poor people 
3) Homeless people    4) Alcoholics 
5) People with HIV/AIDS   6) People with diabetes 
7) Others      8) Don’t know  
 
55. Can TB be cured?    1.No   2. Yes  3. Don’t know 
 
56. How can a person suffering from TB be cured? (Unprompted, multiple options possible)  
1) Herbs medicines  
2) Praying 
3) Resting at home without taking any medicine 
4) Taking Medicationregularly as prescribed by a doctor or a health center 
5) Tuberculosis medication administered/ supervised by DOTS provider 
6) Taking proper diet 
7) Others  
8) Don’t know  
 
57. What is the approximate duration of treatment?  
58. Are you expected to check your sputum sometimes after starting treatment?  
1) No  2) Yes  3) Don’t know 
59. If yes to Q No 58, how many times?  
 
60. If yes to Q No 58, how many months after starting treatment?  
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QUESTIONNAIRE ON TUBERCULOSIS RELATED STIGMA 
A. Community perspective towards tuberculosis (from person with TB) 
  Strongly 
disagree 
Disagree Agree Strongly 
agree  
1 Some people may not want to eat or drink with friends who have 
T.B 
    
2 Some people feel uncomfortable about being near those with T.B     
3 If a person has T.B, some community members will behave 
differently towards that person for the rest of his/her life 
    
4 Some people do not want those with TB playing with their children     
5 Some people keep their distance from people with TB     
6 Some people think that those with TB are disgusting     
7 Some people do not to talk with others about TB     
8 Some people are afraid of those with TB     
9 Some people try not to touch others with TB     
10 Some people may not want to eat or drink with relatives who have 
TB 
    
11 Some people not to have those with TB live in their community     
B. Patient perspectives towards tuberculosis (from person with TB) 
  Strongly 
disagree 
Disagree Agree Strongly 
agree  
1 Some people who have TB feel hurt of how others react to 
knowing they have TB 
    
2 Some people who have TB lose friends when they share with them 
they have TB 
    
3 Some people who have TB feel alone     
4 Some people who have TB keep their distance from others to avoid 
spreading TB germs 
    
5 Some people who have TB are afraid to tell those outside their 
family that they have TB 
    
6 Some people who have TB are afraid of going to TB clinics 
because other people may see them there 
    
7 Some people who have TB are afraid to tell others that they have 
TB because others may think that they also have AIDS 
    
8 Some people who have TB feel guilty because their family has the 
burden of caring for them 
    
9 Some people who have TB Some people who have TB will choose 
carefully who they tell about having TB 
    
10 Some people who have TB feel guilty for getting TB because of 
their smoking, drinking, or other careless behavior s 
    
11 Some people who have TB are worried about having AIDS     
12 Some people who have TB are afraid to tell their family that they 
have TB 
    
How can stigma affect a person with TB in a negative way? (Write literally) 
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Community’s perception: 
A. Community perspective towards tuberculosis (from community member) 
  Strongly 
disagree 
Disagree Agree Strongly 
agree  
1 Some people may not want to eat or drink with friends who have 
T.B 
    
2 Some people feel uncomfortable about being near those with T.B     
3 If a person has T.B, some community members will behave 
differently towards that person for the rest of his/her life 
    
4 Some people do not want those with TB playing with their children     
5 Some people keep their distance from people with TB     
6 Some people think that those with TB are disgusting     
7 Some people do not to talk with others about TB     
8 Some people are afraid of those with TB     
9 Some people try not to touch others with TB     
10 Some people may not want to eat or drink with relatives who have 
TB 
    
11 Some people not to have those with TB live in their community     
B. Patient perspectives towards tuberculosis (from community member) 
  Strongly 
disagree 
Disagree Agree Strongly 
agree  
1 Some people who have TB feel hurt of how others react to 
knowing they have TB 
    
2 Some people who have TB lose friends when they share with them 
they have TB 
    
3 Some people who have TB feel alone     
4 Some people who have TB keep their distance from others to avoid 
spreading TB germs 
    
5 Some people who have TB are afraid to tell those outside their 
family that they have TB 
    
6 Some people who have TB are afraid of going to TB clinics 
because other people may see them there 
    
7 Some people who have TB are afraid to tell others that they have 
TB because others may think that they also have AIDS 
    
8 Some people who have TB feel guilty because their family has the 
burden of caring for them 
    
9 Some people who have TB Some people who have TB will choose 
carefully who they tell about having TB 
    
10 Some people who have TB feel guilty for getting TB because of 
their smoking, drinking, or other careless behaviors 
    
11 Some people who have TB are worried about having AIDS     
12 Some people who have TB are afraid to tell their family that they 
have TB 
    
How can stigma affect a person with TB in a negative way? (Write literally) 
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